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Governments have the responsibility to provide basic services, including health care, to their 
citizens. However, the public sector is not sufficiently well-equipped and financed to provide 
high quality health services that are accessible to all. 1 This explains why private healthcare 
providers playa major role in health service provision in many low and middle-income 
countries.2-6 The private health sector is not homogeneous, but consists of for-profit and not-
for-profit providers as well as formal and informal providers of health care. The private for-
profit sector refers to the part of the economy that is run by individuals and companies for 
profit and is not state-controlled. On the other hand, private not-for-profit providers refer to 
organisations that use surplus revenues to achieve their goals, rather than distributing them as 
profit or dividends. 
There is growing concern that health care provided in the private sector is not always of high 
technical quality.2, 3, 6 Given the need to work with the private sector to increase access to 
services, various strategies have been proposed that governments can employ to engage the 
private sector in service provision.6 These include regulation, contracting, financing and 
social marketing, training, and coordination. 1,6 These interventions are generally applied in 
combination to reach two important goals: (1) improving the quality of care delivered by 
existing service providers; and (2) expanding the coverage of private sector services and 
rationalising this coverage with that of public sector providers.6 However, there is a paucity 
of systematic reviews on the effects of these interventions on the quality and accessibility of 
private for-profit health care in low and middle-income countries. 1, 2,6 We therefore initiated 












AI.I. Description of the condition 
Scarce government resources in low and middle-income countries have led to a decline in the 
quantity and quality of public health services.2,4,6, 7 These public health failures have led to a 
drastic increase in private providers of health services, both for-profit and not-for profit, in 
many low and middle-income countries. lo9 The consequence of this expansion in the private 
health sector is that (poor) communities spend outsized amounts of money for private health 
services; at times when cheaper public sector alternatives are available.3, 4, 6 However, the 
suitability and quality of the services provided by the private health sector is increasingly 
being questioned?' 6 
AI.2. Description of the intervention 
The growing concern regarding the technical failures of health care provided by the private 
for-profit sector has led to the development of interventions aimed at addressing these 
limitations, which simultaneously take advantage of the potential for involving the private 
for-profit sector to achieve public health goals.9 This review will assess the public 
stewardship of private for-profit healthcare providers in low and middle-income countries. 
Public stewardship refers to government policies, regulatory mechanisms and implementation 
strategies for ensuring guidance and accountability.10 Various strategies have been proposed 
for improving the functioning of the private for-profit health sector in order to increase the 
quality, availability, and afIordability of health care for poor people in low and middle 
income countries. 1,4, 6, 7 These strategies include regulation, contracting, social marketing, 
franchising, use of vouchers, training, pay for performance, and coordination. We will focus 
on three types of strategic interventions, namely, regulation, training, and coordination. 
Regulation refers to the setting and enforcing of standards for the private sector; training 
involves educating and supporting private service providers; and coordination entails 













will exclude potential interventions which are already covered by systematic reviews 
published in the last three years; such as social marketing and franchising, 11 contracting, 12 
and pay for performance. 13 
At.3. How the intervention might work 
Regulatory interventions take the form of rules, enforcement systems and sanction 
mechanisms, and can be applied at the levels of the healthcare provider, organisation, or 
facility. At the provider level, regulation may include requirements for pre-service training, 
continuing education, licensing, and certification of providers. At the organisational or 
facility level, regulation may aim to control the location of facilities, their registration, prices 
and minimum complement of staff or facilities. Pharmaceutical market regulation aims to 
limit the availability of harmful drugs and unregistered products, minimise drug misuse, 
control the sale of specific drugs through prescriptions, and control drug manufacture and 
importation.9 Training interventions may involve formal training sessions (educational 
meetings, workshops), vendor-to-vendor education, distribution of guidelines, printed 
educational materials, educational outreach i.e. a personal visit by a trained government 
official to private healthcare providers in their own settings, and audit and feedback i.e. a 
summary of the performance of private for-profit providers over a specified period of time 
given in a verbal or written format; 4,6, 14-16 alone or in combination. A wide variety of private 
sector components could be targeted for training, including physicians, pharmacists, 
midwives, nurses, and traditional healers. Finally, government coordination of private for-
profit health care would ensure harmonised minimum standards for health service delivery 
across geographic areas and social groupS.6 The ultimate aim of government regulatory, 
training, and coordination interventions is to promote better health outcomes and financial 











Al.4. Why it is important to do this review 
A systematic review published in 2007 found "evidence that effective public-private 
partnerships can increase access, improve equity, and raise quality of health services".4 
However, using the GRADE approach,17, 18 this evidence on the effectiveness of interventions 
for working with the private for-profit sector to improve the utilisation and quality of health 
services for the poor in low and middle- income countries was found to be of low quality.9 
The implication of the low quality of the evidence is that further research on this topic is very 
likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. It is possible that additional primary studies may have been conducted 
on this topic. Therefore there is a great need for current best evidence on interventions for 
working with private for-profit healthcare providers to improve access and quality of health 
services. We plan to review the currently available evidence on public sector efforts to work 
with private for-profit health service providers to improve existing health services and expand 
and rationalise the coverage of these services.6 
Al. Objectives 
To assess the effects of public sector regulation, training, or coordination of health services 
provided by the private for-profit sector in low and middle-income countries. 
A3. Methods 
A3.1. Criteria for considering studies for this review 
A3.1.1. Types of studies 
We will consider the following study designs: randomised controlled trials (RCTs) and non-
randomised control trials which include controlled clinical trials (CCTs), interrupted time 












We will include both individually-randomised and cluster-randomised controlled trials. We 
will include an ITS study only if outcomes are measured during at least three points before 
and three points after the intervention, and will exclude simple pre-post designs. To be 
included in the review, a CBA study must include at least two intervention groups and at least 
two comparable control groups, with simultaneous data collection. 
A3.1.2. Types of participants 
Studies taking place in low and middle income countries as defined by the World Bank. All 
types of health services provided the private for-profit sector will be included in our review. 
A3.1.3. Types of interventions 
Regulation, training, or coordination of any intensity or duration; implemented by the public 
sector. The control must be a no-intervention or alternate-intervention group. 
Regulation refers to the setting and enforcing of standards for the private sector; training 
involves educating and supporting private service providers; and coordination entails 
organising and creating alliances among private and public healthcare providers. 
A3.1.4. Types of outcome measures 
A3.1.4.1. Primary outcomes 
• Quality of care (measured as adherence to recommended practice or guidelines). 
A3.1.4.2. Secondary outcomes 
• Mortality or morbidity. 
• Resource use. 
• Adverse effects (e.g. undesirable impacts on existing public or private services, 
inappropriate use of services, distortions in the provision of services). 
• Satisfaction of both health provider and patient. 
• Attitudes of both health provider and patient. 











A comprehensive search will be performed to identify both published and unpublished 
articles with no language restriction. The search strategies for electronic databases will 
incorporate validated search strategy for RCTs, non-RCTs, CBAs, and ITS studies combined 
with relevant MeSH and free-text terms relating to health regulation, training and 
coordination literature for low and middle-income countries. The detailed search strategy is 
provided in section A appendix 6.1. 
A3.2.I. Electronic searches 
We will search the following electronic databases for primary studies: 
• Cochrane Central Register of Controlled Trials (CENTRAL) 
• MEDLINE 
• EMBASE 
• Science Citation Index and Social Sciences Citation Index 
A3.2.2. Searching other resources 
We will search for related reviews in the Cochrane Database of Systematic Reviews (CDSR), 
Database of Abstracts of Reviews of Effectiveness (DARE), and PubMed. Reference lists of 
relevant reviews identified and full-text articles reviewed for inclusion in the review will be 
checked for additional information. We will also search the World Health Organization 
(WHO) Library Information System (WHOLIS) and the WHO Clinical Trials Registry 
Platform. 
A3.3. Data collection and analysis 
A3.3.I. Selection of studies 
We will use the inclusion criteria described above to develop a screening guide, which we 
will pilot to ensure that the criteria are clear to, and can be consistently applied by all review 
authors. We (LA, CW) will independently screen the titles and abstracts of studies identified 











eligible by at least one of the two authors, and discard the rest. LA will obtain the full text of 
all potentially eligible articles, and LA and CW will independently examine each of these for 
eligibility. Each of the two review authors will compile a list of studies which he or she 
believes meet the inclusion criteria. Both authors will then compare their list of included and 
excluded studies, resolving any discrepancies by discussion and consensus. 
A3.3.2. Data extraction and management 
Two authors (LA, CW) will independently extract descriptive and outcome data for each 
paper using a pre-designed data collection checklist. Detailed data extraction form is 
provided in section A appendix 6.2 . Both authors will compare their list of included and 
excluded studies, resolving any discrepancies by discussion and consensus. One review 
author (LA) will compile these data and enter the final outcome data into Review Manager 
(RevMan) 5.1 for meta-analysis. A second review author (CW) will perform double checks in 
RevMan to ensure that there are no errors in the data entered. 
A3.3.3. Assessment of risk of bias in included studies 
We will assess the risk of bias based on six standard domains (as appropriate) 19 : 
• Sequence generation 
• Concealment of allocation 
• Blinded or objective assessment of primary outcome(s) 
• Incomplete outcome data 
• Selective outcome reporting 
• Other source of bias. 
For each included study, we will report our assessment of risk of bias i.e. low, high or 
unclear risk for each domain together with a descriptive summary of the information that 
influenced our judgment. 











We will group measures of treatment effect based on outcome variables. For dichotomous 
outcomes, results from each trial will be expressed as a risk ratio (RR) with 95% confidence 
intervals. We will transform ordinal outcomes into binary data when possible. Continuous 
outcomes may be presented in several ways. When absolute values of post-intervention 
means and standard deviations (SD) are given, using the same rating across studies, we will 
use these to calculate the mean difference (MD) and 95% confidence intervals. If different 
scales are used to measure the same outcomes, we will calculate the standardised mean 
difference (SMD) with 95% confidence intervals (CI). We will analyse ITS studies using 
either a regression analysis with time trends before and after the intervention, which adjusts 
for autocorrelation and any periodic changes; or any other technique that adjusts for 
autocorrelation and secular trends. We will present results for the outcomes as changes along 
two dimensions: change in level and change in slope. Change in level is the immediate effect 
of the policy and change in slope is the change in the trend from pre- to post-intervention. It 
reflects the long-term effect of the intervention. 
A3.3.S. Unit of analysis issues 
If investigators report cluster-randomised trial data as if the randomisation was performed on 
the individuals rather than the clusters, we will request the intra-cluster correlation coefficient 
(ICC) from the study authors; failing which we will obtain external estimates of the ICC from 
similar studies or available resources.20 Once established, we will use the ICC to re-analyse 
the trial data to obtain approximate correct analyses.21 We plan to combine the effect 
estimates and their corrected standard errors from cluster-randomised trials with those from 
parallel group designs using the generic inverse variance method.19 If insufficient information 
is available to control for clustering in this way, we will enter data into RevMan using 
individuals as the unit of analysis. We will then perform sensitivity analyses to assess the 
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trials. We will also perform sensitivity analyses if the ICCs were obtained from external 
somces to assess the potential biasing effects of inadequately controlled cluster-randomised 
trialS?l 
A3.3.6. Dealing with missing data 
Where necessary, we will contact the corresponding authors of included studies to supply any 
unreported data. If the corresponding author does not respond within one week of om request, 
we will contact other authors (copying in the corresponding author). Ifa study reports 
outcomes only for participants completing the trial or only for participants who followed the 
protocol, we will contact the authors and ask them to provide additional information to permit 
us to conduct meta-analyses by intention-to-treat. We will describe missing data and dropouts 
for each included study in the Risk of Bias table, and discuss the extent to which the missing 
data could alter om results. We will conduct sensitivity analyses to assess the effect of 
missing data on om primary meta-analyses. 
A3.3. 7. Assessment of heterogeneity 
If we find studies of similar interventions that report similar outcomes, we will examine 
statistical heterogeneity between study results using the Chi2 test of homogeneity (with 
significance defined at the 10% alpha-level), and quantify any statistical heterogeneity 
between study results using the 12 statistic. 19 
A3.3.8. Data synthesis 
If we identify two or more studies with similar interventions and comparison groups that 
report similar outcome measures, we will use meta-analysis to estimate the overall effect 
across those studies. We will pool the data using random-effects method because we 
anticipate significant heterogeneity. We will calculate all overall effects, if applicable, using 
inverse variance methods. 














We do not plan any subgroup analyses since we anticipate that studies might not be similar 
enough to directly compare the estimates of effect. We will stratify analysis by type of 
intervention (Le. regulation, training, and coordination) and study design. 
A3.3.9. Sensitivity analysis 
If we find studies that are similar enough that it would be sensible to combine them in a meta-
analysis, we will conduct sensitivity analyses to investigate the robustness of the results to 
risk of bias (Le. omitting any studies with high risk of bias) and method of meta-analysis (Le., 
random-effects versus fixed-effect). 
A3.3.10. Grading the quality of evidence 
We will use the GRADE approach to assess the quality of evidence related to the primary 
outcome.18 The GRADE approach results in an assessment of the quality of a body of 
evidence as high, moderate, low, or very low.18 High quality evidence implies that "further 
research is very unlikely to change our confidence in the estimate of effect". Moderate 
quality evidence means that "further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate". Evidence is considered of 
low quality if "further research is very likely to have an important impact on our confidence 
in the estimate of effect and is likely to change the estimate", and very low quality if "we 
have very little confidence in the effect estimate". 17 There are a number of factors that affect 
the quality of evidence. These include but not limited to: study limitations, inconsistency of 
results, indirectness of evidence, imprecision, and reporting bias. 18 
A4. Ethics 
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A6.1. Sear~h strategy 
CENTRAL (Co~hrane Library) 
# Sear~hes 
# 1 MeSH descriptor Public-Private Sector Partnerships, this term only 
#2 MeSH descriptor Private Sector, this term only 
#3 MeSH descriptor Private Practice, this term only 
#4 MeSH descriptor Hospitals, Private, this term only 
#5 MeSH descriptor Privatization, this term only 
#6 privat* :ti,ab 
#7 MeSH descriptor Public Sector, this term only 
#8 MeSH descriptor Public Policy, this term only 
#9 MeSH descriptor Health Policy, this term only 
#10 MeSH descriptor State Dentistry, this term only 
# 11 MeSH descriptor Health Care Reform, this term only 
#12 MeSH descriptor Health Planning, this term only 
#13 MeSH descriptor Social Control, Formal, this term only 
# 14 MeSH descriptor Law Enforcement, this term only 
# 15 MeSH descriptor Government explode all trees 
# 16 MeSH descriptor Government Regulation, this term only 
#17 MeSH descriptor Facility Regulation and Control, this term only 
#18 MeSH descriptor Policy Making, this term only 
#19 MeSH descriptor Jurisprudence, this term only 
#20 MeSH descriptor Mandatory Reporting, this term only 
#21 MeSH descriptor Politics, this term only 
#22 MeSH descriptor Legislation as Topic, this term only 
#23 MeSH descriptor Legislation, Hospital, this term only 
#24 MeSH descriptor Legislation, Medical, this term only 
#25 MeSH descriptor Legislation, Nursing, this term only 
#26 MeSH descriptor Legislation, Pharmacy, this term only 
#27 MeSH descriptor Legislation, Drug, this term only 
#28 MeSH descriptor Legislation, Dental, this term only 
#29 (public* or stewardship* or governance or governing or coordinat* or co NEXT 
ordinat* or legislat* or regulat* or government* or law or laws or act or acts or policy or 
policies or politics or reform* or control* or supervis* or monitor*):ti,ab 
#30 MeSH descriptor Physician's Practice Patterns, this term only 
#31 MeSH descriptor Nurse's Practice Patterns, this term only 
#32 MeSH descriptor Dentist's Practice Patterns, this term only 












#34 MeSH descriptor Malpractice, this tenn only 
#35 MeSH descriptor Professional Impainnent, this tenn only 
#36 MeSH descriptor Physician Impainnent, this tenn only 
#37 MeSH descriptor Medical Errors, this tenn only 
#38 MeSH descriptor Diagnostic Errors, this tenn only 
#39 MeSH descriptor Medication Errors explode all trees 
#40 MeSH descriptor Professional Competence, this tenn only 
#41 MeSH descriptor Clinical Competence, this tenn only 
#42 (competence or practice NEXT pattern* or malpractice or mal NEXT practice or 
error*):ti,ab 
#43 MeSH descriptor Education, this tenn only 
#44 MeSH descriptor Competency-Based Education, this tenn only 
#45 MeSH descriptor Education, Public Health Professional, this tenn only 
#46 MeSH descriptor Education, Medical, this tenn only 
#47 MeSH descriptor Education, Medical, Continuing, this tenn only 
#48 MeSH descriptor Education, Nursing, this tenn only 
#49 MeSH descriptor Education, Nursing, Continuing, this tenn only 
#50 MeSH descriptor Education, Dental, this tenn only 
#51 MeSH descriptor Education, Dental, Continuing, this tenn only 
#52 MeSH descriptor Education, Pharmacy, this tenn only 
#53 MeSH descriptor Education, Phannacy, Continuing, this tenn only 
#54 (educat* or train or training or trained or colloquium* or conference* or course* or 
lecture* or meeting* or seminar* or support* or symposi* or workshop*):ti,ab 
#55 MeSH descriptor Delivery of Health Care, this tenn only 
#56 MeSH descriptor Quality of Health Care, this tenn only 
#57 MeSH descriptor Quality Assurance, Health Care, this tenn only 
#58 MeSH descriptor Quality Improvement, this tenn only 
#59 MeSH descriptor Total Quality Management, this tenn only 
#60 MeSH descriptor Outcome and Process Assessment (Health Care), this tenn only 
#61 MeSH descriptor Outcome Assessment (Health Care), this tenn only 
#62 MeSH descriptor Process Assessment (Health Care), this tenn only 
#63 MeSH descriptor Guideline Adherence, this tenn only 
#64 MeSH descriptor Benchmarking, this tenn only 
#65 MeSH descriptor Standard of Care, this tenn only 
#66 MeSH descriptor Reference Standards, this tenn only 
#67 (best NEXT practice or quality or standard* or benchmark* or adherence or 
requirement*):ti,ab 
#68 (Africa or Asia or Caribbean or "West Indies" or "South America" or "Latin America" or 
"Central America"):ti,ab,kw 
#69 (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
















Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or "Burkina Faso" or "Burkina Fasso" or "Upper Volta" or Burundi or Urundi or 
Cambodia or "Khmer Republic" or Kampuchea or Cameroon or Cameroons or Cameron 
or Camerons or "Cape Verde" or "Central African Republic" or Chad or Chile or China 
or Colombia or Comoros or "Comoro Islands" or Comores or Mayotte or Congo or Zaire 
or "Costa Rica" or "Cote d'Ivoire" or "Ivory Coast" or Croatia or Cuba or Cyprus or 
Czechoslovakia or "Czech Republic" or Slovakia or "Slovak Republic"):ti,ab,kw 
#70 (Djibouti or "French Somaliland" or Dominica or "Dominican Republic" or "East Timor" 
or "East Timur" or "Timor Leste" or Ecuador or Egypt or "United Arab Republic" or "EI 
Salvador" or Eritrea or Estonia or Ethiopia or Fiji or Gabon or "Gabonese Republic" or 
Gambia or Gaza or Georgia or Georgian or Ghana or "Gold Coast" or Greece or Grenada 
or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary 
or India or Maldives or Indonesia or Iran or Iraq or "Isle of Man" or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or "Kyrgyz Republic" or Kirghiz or Kirgizstan or "Lao PDR" or Laos or Latvia 
or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,kw 
#71 (Macedonia or Madagascar or "Malagasy Republic" or Malaysia or Malaya or Malay or 
Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or "Marshall Islands" or 
Mauritania or Mauritius or "Agalega Islands" or Mexico or Micronesia or "Middle East" 
or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni 
or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or "Netherlands 
Antilles" or "New Caledonia" or Nicaragua or Niger or Nigeria or "Northern Mariana 
Islands" or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or 
Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or 
"Puerto Rico"):ti,ab,kw 
#72 (Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or "Saint 
Kitts" or "St Kitts" or Nevis or "Saint Lucia" or "St Lucia" or "Saint Vincent" or "St 
Vincent" or Grenadines or Samoa or "Samoan Islands" or ''Navigator Island" or 
"Navigator Islands" or "Sao Tome" or "Saudi Arabia" or Senegal or Serbia or 
Montenegro or Seychelles or "Sierra Leone" or Slovenia or "Sri Lanka" or Ceylon or 
"Solomon Islands" or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria 
or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo 
or "Togolese Republic" or Tonga or Trinidad or Tobago or Tunisia or Turkey or 
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or "Soviet Union" 
or "Union of Soviet Socialist Republics" or Uzbekistan or Uzbek or Vanuatu or "New 
Hebrides" or Venezuela or Vietnam or "Viet Nam" or "West Bank" or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia):ti,ab,kw 
#73 (developing or less· NEXT developed or "under developed" or underdeveloped or 
"middle income" or low· NEXT income or underserved or "under served" or deprived or 
poor·) NEXT (countr· or nation· or population· or world):ti,ab,kw 
#74 (developing or less· NEXT developed or "under developed" or underdeveloped or 
"middle income" or low· NEXT income) NEXT (economy or economies):ti,ab,kw 
#75 low· NEXT (gdp or gnp or "gross domestic" or "gross national"):ti,ab,kw 
#76 (low NEARl3 middle NEARl3 countr·):ti,ab,kw 
#77 (lmic or lmics or "third world" or "lami country" or "lami countries"):ti,ab,kw 












#79 (#2 OR #3 OR #4 OR #5 OR #6) 
#80 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 
OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR 
#28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 
OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR 
#49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 
OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67) 
#81 (#68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR 
#78) 
#82 (#1 AND #81) 
#83 (#79 AND #80 AND #81) 
#84 (#82 OR #83) 
DARE (Cochrane Library) 
# Searches 
#1 MeSH descriptor Public-Private Sector Partnerships, this term only 
#2 MeSH descriptor Private Sector, this term only 
#3 MeSH descriptor Private Practice, this term only 
#4 MeSH descriptor Hospitals, Private, this term only 
#5 MeSH descriptor Privatization, this term only 
#6 privat* :ti,ab 
#7 MeSH descriptor Public Sector, this term only 
#8 MeSH descriptor Public Policy, this term only 
#9 MeSH descriptor Health Policy, this term only 
#10 MeSH descriptor State Dentistry, this term only 
#11 MeSH descriptor Health Care Reform, this term only 
#12 MeSH descriptor Health Planning, this term only 
#13 MeSH descriptor Social Control, Formal, this term only 
#14 MeSH descriptor Law Enforcement, this term only 
#15 MeSH descriptor Government explode all trees 
#16 MeSH descriptor Government Regulation, this term only 
#17 MeSH descriptor Facility Regulation and Control, this term only 
#18 MeSH descriptor Policy Making, this term only 
#19 MeSH descriptor Jurisprudence, this term only 
#20 MeSH descriptor Mandatory Reporting, this term only 
#21 MeSH descriptor Politics, this term only 
#22 MeSH descriptor Legislation as Topic, this term only 
#23 MeSH descriptor Legislation, Hospital, this term only 
#24 MeSH descriptor Legislation, Medical, this term only 
#25 MeSH descriptor Legislation, Nursing, this term only 
#26 MeSH descriptor Legislation, Pharmacy, this term only 











#28 MeSH descriptor Legislation, Dental, this term only 
#29 (public* or stewardship* or governance or governing or coordinat* or co NEXT 
ordinat* or legislat* or regulat* or government* or law or laws or act or acts or policy or 
policies or politics or reform* or control* or supervis* or monitor*):ti,ab 
#30 MeSH descriptor Physician's Practice Patterns, this term only 
#31 MeSH descriptor Nurse's Practice Patterns, this term only 
#32 MeSH descriptor Dentist's Practice Patterns, this term only 
#33 MeSH descriptor Health Knowledge, Attitudes, Practice, this term only 
#34 MeSH descriptor Malpractice, this term only 
#35 MeSH descriptor Professional Impairment, this term only 
#36 MeSH descriptor Physician Impairment, this term only 
#37 MeSH descriptor Medical Errors, this term only 
#38 MeSH descriptor Diagnostic Errors, this term only 
#39 MeSH descriptor Medication Errors explode all trees 
#40 MeSH descriptor Professional Competence, this term only 
#41 MeSH descriptor Clinical Competence, this term only 
#42 (competence or practice NEXT pattern* or malpractice or mal NEXT practice or 
error*):ti,ab 
#43 MeSH descriptor Education, this term only 
#44 MeSH descriptor Competency-Based Education, this term only 
#45 MeSH descriptor Education, Public Health Professional, this term only 
#46 MeSH descriptor Education, Medical, this term only 
#47 MeSH descriptor Education, Medical, Continuing, this term only 
#48 MeSH descriptor Education, Nursing, this term only 
#49 MeSH descriptor Education, Nursing, Continuing, this term only 
#50 MeSH descriptor Education, Dental, this term only 
#51 MeSH descriptor Education, Dental, Continuing, this term only 
#52 MeSH descriptor Education, Pharmacy, this term only 
#53 MeSH descriptor Education, Pharmacy, Continuing, this term only 
#54 (educat* or train or training or trained or colloquium* or conference* or course* or 
lecture* or meeting* or seminar* or support* or symposi* or workshop*):ti,ab 
#55 MeSH descriptor Delivery of Health Care, this term only 
#56 MeSH descriptor Quality of Health Care, this term only 
#57 MeSH descriptor Quality Assurance, Health Care, this term only 
#58 MeSH descriptor Quality Improvement, this term only 
#59 MeSH descriptor Total Quality Management, this term only 
#60 MeSH descriptor Outcome and Process Assessment (Health Care), this term only 
#61 MeSH descriptor Outcome Assessment (Health Care), this term only 
#62 MeSH descriptor Process Assessment (Health Care), this term only 
#63 MeSH descriptor Guideline Adherence, this term only 











#65 MeSH descriptor Standard of Care, this term only 
#66 MeSH descriptor Reference Standards, this term only 
#67 (best NEXT practice or quality or standard* or benchmark* or adherence or 
requirement*):ti,ab 
#68 (Africa or Asia or Caribbean or "West Indies" or "South America" or "Latin America" or 
"Central America"):ti,ab,kw 
#69 (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or "Burkina Faso" or "Burkina Fasso" or "Upper Volta" or Burundi or Urundi or 
Cambodia or "Khmer Republic" or Kampuchea or Cameroon or Cameroons or Cameron 
or Camerons or "Cape Verde" or "Central African Republic" or Chad or Chile or China 
or Colombia or Comoros or "Comoro Islands" or Comores or Mayotte or Congo or Zaire 
or "Costa Rica" or "Cote d'Ivoire" or "Ivory Coast" or Croatia or Cuba or Cyprus or 
Czechoslovakia or "Czech Republic" or Slovakia or "Slovak: Republic"):ti,ab,kw 
#70 (Djibouti or "French Somaliland" or Dominica or "Dominican Republic" or "East Timor" 
or "East Timur" or "Timor Leste" or Ecuador or Egypt or "United Arab Republic" or "EI 
Salvador" or Eritrea or Estonia or Ethiopia or Fiji or Gabon or "Gabonese Republic" or 
Gambia or Gaza or Georgia or Georgian or Ghana or "Gold Coast" or Greece or Grenada 
or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary 
or India or Maldives or Indonesia or Iran or Iraq or "Isle of Man" or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or "Kyrgyz Republic" or Kirghiz or Kirgizstan or "Lao PDR" or Laos or Latvia 
or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,kw 
#71 (Macedonia or Madagascar or "Malagasy Republic" or Malaysia or Malaya or Malay or 
Sabah or Sarawak: or Malawi or Nyasaland or Mali or Malta or "Marshall Islands" or 
Mauritania or Mauritius or "Agalega Islands" or Mexico or Micronesia or "Middle East" 
or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni 
or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or "Netherlands 
Antilles" or "New Caledonia" or Nicaragua or Niger or Nigeria or "Northern Mariana 
Islands" or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or 
Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or 
"Puerto Rico"):ti,ab,kw 
#72 (Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or "Saint 
Kitts" or "St Kitts" or Nevis or "Saint Lucia" or "St Lucia" or "Saint Vincent" or "St 
Vincent" or Grenadines or Samoa or "Samoan Islands" or "Navigator Island" or 
"Navigator Islands" or "Sao Tome" or "Saudi Arabia" or Senegal or Serbia or 
Montenegro or Seychelles or "Sierra Leone" or Slovenia or "Sri Lanka" or Ceylon or 
"Solomon Islands" or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria 
or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo 
or "Togolese Republic" or Tonga or Trinidad or Tobago or Tunisia or Turkey or 
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or "Soviet Union" 
or "Union of Soviet Socialist Republics" or Uzbekistan or Uzbek or Vanuatu or "New 
Hebrides" or Venezuela or Vietnam or "Viet Nam" or "West Bank" or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia):ti,ab,kw 











"middle income" or low* NEXT income or underserved or "under served" or deprived or 
poor*) NEXT (countr* or nation* or population* or world):ti,ab,kw 
#74 (developing or less* NEXT developed or "under developed" or underdeveloped or 
"middle income" or low* NEXT income) NEXT (economy or economies):ti,ab,kw 
#75Iow* NEXT (gdp or gnp or "gross domestic" or "gross national"):ti,ab,kw 
#76 (low NEAR!3 middle NEAR!3 countr*):ti,ab,kw 
#77 (lmic or lmics or "third world" or "lami country" or "lami countries"):ti,ab,kw 
#78 ("transitional country" or "transitional countries"):ti,ab,kw 
#79 (#2 OR #3 OR #4 OR #5 OR #6) 
#80 (#7 OR #8 OR #9 OR#IO OR#11 OR#12 OR #13 OR#14 OR#15 OR#16 OR#17 
OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR 
#28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 
OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR 
#49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 
OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67) 
#81 (#68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR 
#78) 
#82 (#1 AND #81) 
#83 (#79 AND #80 AND #81) 
#84 (#82 OR #83) 
MEDLINE In-Process & Other Non-Indexed Citations and MEDLINE (Ovid) 
# Searches 
1 Public-Private Sector Partnerships/ 
2 Private Sector/ 
3 Private Practice/ 
4 Hospitals, Private/ 
5 Privatization! 
6 privat* .ti,ab. 
7 or/2-6 
8 Public Sector/ 
9 Public Policy/ 
10 Health Policy/ 
11 State Medicine/ 
12 State Dentistry/ 
13 Health Care Reform! 
14 Health Planning! 
15 Social Control, F ormall 
16 Law Enforcement! 
17 exp Government! 
18 Government Regulation! 










































































(public* or stewardship* or governance or governing or coordinat* or co ordinat* or 
legislat* or regulat* or government* or law or laws or act or acts or policy or policies or 
politics or reform* or control* or supervis* or monitor*).ti,ab. 
or/8-31 
Physician's Practice Patterns! 
Nurse's Practice Patterns! 
Dentist's Practice Patterns! 













Education, Public Health Professional! 
Education, Medical! 
Education, Medical, Continuing! 
Education, Nursing! 
Education, Nursing, Continuing! 
Education, Dental! 
Education, Dental, Continuing! 
Education, Pharmacy/ 
Education, Pharmacy, Continuing! 



































lecture? or meeting? or seminar? or support* or symposi* or workshop?).ti,ab. 
or/47-58 
"Delivery of Health Care"/ 
"Quality of Health Care"/ 
Quality Assurance, Health Carel 
Quality Improvement! 
Total Quality Management! 
"Outcome and Process Assessment (health care )"/ 
"Outcome Assessment (health care)"/ 





(best practice or quality or standard* or benchmark* or adherence or requirement*).ti,ab. 
or/60-72 
Developing Countries.sh,kf. 
(Africa or Asia or Caribbean or West Indies or South America or Latin America or 
Central America).hw,kf,ti,ab,cp. 
(Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or Urundi or 
Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or 
Camerons or Cape Verde or Central African Republic or Chad or Chile or China or 
Colombia or Comoros or Comoro Islands or Comores or Mayotte or Congo or Zaire or 
Costa Rica or Cote d'Ivoire or Ivory Coast or Croatia or Cuba or Cyprus or 
Czechoslovakia or Czech Republic or Slovakia or Slovak Republic or Djibouti or French 
Somaliland or Dominica or Dominican Republic or East Timor or East Timur or Timor 
Leste or Ecuador or Egypt or United Arab Republic or EI Salvador or Eritrea or Estonia 
76 or Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia 
Republic or Georgian Republic or Ghana or Gold Coast or Greece or Grenada or 
Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or 
India or Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia or 
Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or 
Madagascar or Malagasy Republic or Malaysia or Malaya or Malay or Sabah or Sarawak 
or Malawi or Nyasaland or Mali or Malta or Marshall Islands or Mauritania or Mauritius 
or Agalega Islands or Mexico or Micronesia or Middle East or Moldova or Moldovia or 
Moldovian or Mongolia or Montenegro or Morocco or Ifni or Mozambique or Myanmar 
or Myanma or Burma or Namibia or Nepal or Netherlands Antilles or New Caledonia or 
Nicaragua or Niger or Nigeria or Northern Mariana Islands or Oman or Muscat or 
































or Phillipines or Phillippines or Poland or Portugal or Puerto Rico or Romania or 
Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or Saint Kitts or St 
Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St Vincent or Grenadines or 
Samoa or Samoan Islands or Navigator Island or Navigator Islands or Sao Tome or Saudi 
Arabia or Senegal or Serbia or Montenegro or Seychelles or Sierra Leone or Slovenia or 
Sri Lanka or Ceylon or Solomon Islands or Somalia or Sudan or Suriname or Surinam or 
Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania 
or Thailand or Togo or Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or 
Turkey or Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or 
Soviet Union or Union of Soviet Socialist Republics or Uzbekistan or Uzbek or Vanuatu 
or New Hebrides or Venezuela or Vietnam or Viet Nam or West Bank or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia).hw,kf,ti,ab,cp. 
«developing or less* developed or under developed or underdeveloped or middle income 
or low* income or underserved or under served or deprived or poor*) adj (countr* or 
nation? or population? or world».ti,ab. 
«developing or less* developed or under developed or underdeveloped or middle income 
or low* income) adj (economy or economies».ti,ab. 
(low* adj (gdp or gnp or gross domestic or gross national».ti,ab. 
(low adj3 middle adj3 countr*).ti,ab. 
(lmic or lmics or third world or lami countr*).ti,ab. 
transitional countr*.ti,ab. 
or174-82 
randomized controlled trial.pt. 
controlled clinical trial.pt. 
multicenter study.pt. 
(randomis* or randomiz* or randomly or random allocat*).ti,ab. 
groups.ab. 
(trial or multicenter or multi center or multicentre or multi centre).ti. 
(intervention* or controlled or control group or compare or compared or (before adj5 
after) or (pre adj5 post) or pretest or pre test or posttest or post test or quasiexperiment* 





92 not (92 and 93) 
comment.pt. 
editorial. pt. 
97 cochrane database of systematic reviews.jn. 














10291 not 101 
103 1 and 83 and 102 
1047 and 32 and 83 and 102 
1057 and 46 and 83 and 102 
106 7 and 59 and 83 and 102 
1077 and 73 and 83 and 102 
108 or/l 03-1 07 
EMBASE (Ovid) 
# Searches 
1 "organization and management"/ 
2 government regulation! 
3 social controV 
4 professional competence/ 
5 clinical competence/ 
6 quality control/ 
7 health care quality/ 
8 total quality management! 
9 or/2-8 
101 and 9 
(privat· adj6 (public· or stewardship· or governance or governing or coordinat· or co 
11 ordinat· or legislat· or regulat· or government· or law or laws or act or acts or policy or 
policies or politics or reform· or control· or supervis· or monitor·)).ti,ab. 
12 (privat· adj6 (competence or practice pattern· or malpractice or mal practice or 
error·)).ti,ab. 
13 (privat· adj6 (educat· or train or training or trained or colloquium? or conference? or 
course? or lecture? or meeting? or seminar? or support· or symposi· or workshop?)).ti,ab. 
14 (privat· adj6 (best practice or quality or standard· or benchmark· or adherence or 
requirement·)). ti,ab. 
150r/II-14 
1610 or 15 
17 Developing Country.sh. 
18 (Africa or Asia or Caribbean or West Indies or South America or Latin America or Central 
America ).hw, ti,ab,cp. 
(Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
19 Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or Urundi or 
Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or 
Camerons or Cape Verde or Central African Republic or Chad or Chile or China or 
Colombia or Comoros or Comoro Islands or Comores or Mayotte or Congo or Zaire or 











Czechoslovakia or Czech Republic or Slovakia or Slovak Republic or Djibouti or French 
Somali1and or Dominica or Dominican Republic or East Timor or East Timur or Timor 
Leste or Ecuador or Egypt or United Arab Republic or EI Salvador or Eritrea or Estonia or 
Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia Republic 
or Georgian Republic or Ghana or Gold Coast or Greece or Grenada or Guatemala or 
Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or India or 
Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan 
or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz 
Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia or Lebanon or Lesotho or 
Basutoland or Liberia or Libya or Lithuania or Macedonia or Madagascar or Malagasy 
Republic or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland 
or Mali or Malta or Marshall Islands or Mauritania or Mauritius or Agalega Islands or 
Mexico or Micronesia or Middle East or Moldova or Moldovia or Moldovian or Mongolia 
or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or 
Namibia or Nepal or Netherlands Antilles or New Caledonia or Nicaragua or Niger or 
Nigeria or Northern Mariana Islands or Oman or Muscat or Pakistan or Palau or Palestine 
or Panama or Paraguay or Peru or Philippines or Philipines or Phillipines or Phillippines 
or Poland or Portugal or Puerto Rico or Romania or Rumania or Roumania or Russia or 
Russian or Rwanda or Ruanda or Saint Kitts or St Kitts or Nevis or Saint Lucia or St 
Lucia or Saint Vincent or St Vincent or Grenadines or Samoa or Samoan Islands or 
Navigator Island or Navigator Islands or Sao Tome or Saudi Arabia or Senegal or Serbia 
or Montenegro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or Ceylon or 
Solomon Islands or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria or 
Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or 
Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan 
or Turkmen or Uganda or Ukraine or Uruguay or USSR or Soviet Union or Union of 
Soviet Socialist Republics or Uzbekistan or Uzbek or Vanuatu or New Hebrides or 
Venezuela or Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia or Zambia or 
Zimbabwe or Rhodesia).hw,ti,ab,cp. 
«developing or less· developed or under developed or underdeveloped or middle income 
20 or low· income or underserved or under served or deprived or poor·) adj (countr· or 
nation? or population? or world».ti,ab. 
21 «developing or less· developed or under developed or underdeveloped or middle income 
or low· income) adj (economy or economies».ti,ab. 
22 (low· adj (gdp or gnp or gross domestic or gross national».ti,ab. 
23 (low adj3 middle adj3 countr·).ti,ab. 
24 (lmic or lmics or third world or lami countr·).ti,ab. 
25 transitional countr·. ti,ab. 
26or117-25 
27 Randomized Controlled Trial/ 
28 Controlled Clinical Trial/ 
29 Quasi Experimental Study/ 
30 Pretest Posttest Control Group Design! 
31 Time Series Analysis/ 
32 Experimental Design! 










34 (randomis* or randomiz* or randomly or random allocat*).ti,ab. 
35 groups.ab. 
36 (trial or multicentre or multicenter or multi centre or multi center).ti. 
(intervention* or controlled or control group or compare or compared or (before adj5 
37 after) or (pre adj5 post) or pretest or pre test or posttest or post test or quasiexperiment* or 




40 "cochrane database of systematic reviews".jn. 
41 Nonhuman! 
420r/39-41 
4338 not 42 
4416 and 26 and 43 
45 15 and 26 and 43 
46 limit 45 to embase 




TS=(stewardship* or governance or governing or policy or policies or politics or coordinat* 
or legislat* or regulat* or supervis* or monitor*) 
AND 
TS=(health* or medical* or pharmac* or drug or drugs or doctor* or physiscan* or nurse or 
nurses or hospital*) 
AND 
TS=( developing or less developed or lesser developed or underdeveloped or under developed 
or middle income or low income or lower income or transitional) AND TS=( countr* or 
nationS or populationS or world) OR TS=(lmic or lmics) 
AND 
TS=(randomis* or randomiz* or impact or effect or evaluat* or control* or intervention* or 
"time series" or "time point" or "time points" or "repeated measure" or "repeated measures" 
















TS=(partnership$ or engagementS or collaborat*) 
AND 
TS=(health* or medical* or pharmac* or drug or drugs or doctor* or physiscan* or nurse or 
nurses or hospital*) 
AND 
TS=( developing or less developed or lesser developed or underdeveloped or under developed 
or middle income or low income or lower income or transitional) AND TS=( countr* or 
nationS or populationS or world) OR TS=(lmic or lmics) 
AND 
TS=(randomis* or randomiz* or impact or effect or evaluat* or control* or intervention* or 
"time series" or "time point" or "time points" or "repeated measure" or "repeated measures" 
or quasiexperiment* or "quasi experiment") 
WHOLIS (WHO) 
Searched in field: Words or phrase 
privatS AND public AND stewardshipS or governS or policy or policies or politics or 
coordinatS or co ordinatS or legislatS or regulatS or supervis$ or monitorS or partnerS or 
engagementS or collaboratS AND random$ or impactS or effectS or evaluat$ or controlS or 
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Governments have the responsibility to provide basic health services. However, the public 
sector does not provide high quality health services accessible to all. This explains why 
private sector plays a major role but the health care provided is not always of high quality. 
Therefore, there is a need for public-private sector collaboration in order to increase access to 
quality services. 
Objectives 
To assess the effects of government policies on regulation, training or coordination of health 
services provided by the private for-profit sector in low and middle-income countries. 
Search methods 
In Jan 2012, we searched the Cochrane Central Register of Controlled, Medline, EMBASE, 
WHO Library Information System, Web of science, Database of Abstracts of Reviews of 
Effectiveness, Cochrane Database of Systematic Reviews, and the WHO Clinical Trials 
Platform. 
Selection criteria 
Randomised controlled trials and non-randomised control trials which include controlled 
clinical trials, interrupted time series designs, controlled before-after studies, of regulation, 
training and coordination intervention in low and middle income countries. 
nata collection and analysis 
Two authors independently assessed studies for inclusion. The effects of interventions are 
compared using risk ratios (RR) or Standardized mean difference, and presented with 95% 












We identified 7629 studies from the electronic search, 33 of which were potentially eligible. 
We excluded 19 of these studies because they were descriptive in nature and did not involve a 
rigorous evaluation of training, regulation, or coordination of private for-profit healthcare 
providers. The remaining 14 studies met our inclusion criteria: six individual randomised 
controlled trials, three clusters randomised controlled trials, two controlled before and after 
studies and one controlled clinical trial. Thirteen studies assessed training, four assessed 
regulation, and none assessed coordination. These studies generally had a high risk of bias. 
Seven of the 13 studies on training were carried out in Africa and the rest in Asia. These 
studies evaluated a range of private for profit services from pharmaceutical practices to 
prescribing practices. All the four studies on regulation were carried out in Asia i.e. Vietnam 
(2 studies), Thailand and Lao. They mostly targeted private for-profit pharmacy practices. 
The pooled results show no evidence of an effect for individually randomised controlled trials 
(6 studies, 2956 participants, RR 0.99,95% CI 0.70 to 1.39, e=96%), controlled clinical 
trials (1 study, 171 participants, RR 0.89,95% CI 0.74 to 1.06), and controlled before and 
after studies (2 studies, 199 participants, RR 1.37, 95% CI 0.81 to 2.33, 12=0%). However, 
cluster randomised controlled trials show significant beneficial effects on quality of care 
among those who received training compared to those were not offered training (3 studies, 
1154 participants, RR 3.07,95% CI 1.55 to 6.08, 12=91%). In addition one cluster 
randomised controlled trial that reported continuous data also shows a beneficial effect of 
training (1 study, N=4445, mean difference 0.16 CI 0.10 to 0.21). The pooled results of 
regulation do not rule out either a beneficial or harmful effect on quality of care (2 studies, 
306 participants, RR 1.05, 95% CI 0.81 to 1.37, e=49%). The remaining two studies reported 
continuous data; one cluster randomised controlled trial shows a small beneficial effect (1 











randomised controlled trial did not show any evidence of effect (1 study, N=92, mean 
difference 0.07, CI -0.34 to -0.48). We did not find an eligible study on coordination. None 
of the studies reported data on mortality or morbidity, resomce use, adverse effects, 
satisfaction, or attitudes. 
Conclusions 
Cmrently available evidence shows that training probably improves quality of health care in 
the by private for-profit sector. However, the cmrently available evidence does not rule out a 
beneficial or harmful effect of regulation on the quality of care provided by the private for-
profit sector. We found no data on the effects of coordination, thus rigorous studies on this 
intervention are needed. We recommend that further research on the interventions assessed in 
this review should be of high quality and should assess other policy-relevant outcomes such 












Governments have the responsibility to provide basic services, including health care, to their 
citizens. However, the public sector is not sufficiently well-equipped and financed to provide 
high quality health services that are accessible to all. I This explains why private healthcare 
providers playa major role in health service provision in many low and middle-income 
countries?-6 Given the need to work with the private sector to increase access to services, 
various strategies have been proposed that governments can employ to engage the private 
sector in service provision.6 These include regulation, contracting, financing and social 
marketing, training, and coordination. I, 6 These interventions are generally applied in 
combination to reach two important goals: (1) improving the quality of care delivered by 
existing service providers; and (2) expanding the coverage of private sector services and 
rationalising this coverage with that of public sector providers. 6 However, there is a paucity 
of systematic reviews on the effects of these interventions on the quality and accessibility of 
private for-profit health care in low and middle-income countries. I, 2, 6 We therefore initiated 
this review to assess the public stewardship of the private for-profit health sector in low and 
middle-income countries. 
Scarce government resources in low and middle-income countries have led to a decline in the 
quantity and quality of public health services?' so, 6, 7 These public health failures have led to a 
drastic increase in private providers of health services, both for-profit and not-for profit, in 
many low and middle-income countries. I-6, 10, so, 51 The consequence of this expansion in the 
'private health sector is that (poor) communities spend outsized amounts of money for private 
health services; at times when cheaper public sector alternatives are available?' 4, 6 However, 
the suitability and quality of the services provided by the private health sector is increasingly 














1 OJ: h .. 
Public stewardship refers to government policies, regulatory mechanisms and implementation 
strategies for ensuring guidance and accountability.lO We will focus on three types of 
strategic interventions, namely, regulation, training, and coordination; and exclude potential 
interventions which are already covered by systematic reviews published in the last three 
years such as social marketing and franchising, 46 contracting, 48 and pay for performance.49• 
Regulation refers to the setting and enforcing of standards for the private sector; training 
involves educating and supporting private service providers; and coordination entails 
organising and creating alliances among private and public sector healthcare providers. 
A systematic review published in 2007 found "evidence that effective public-private 
partnerships can increase access, improve equity, and raise quality of health services". 4 
However, using the GRADE approach, 8,9 this evidence on the effectiveness of interventions 
for working with the private for-profit sector to improve the utilisation and quality of health 
services for the poor in the low and middle-countries was found to be of low quality.lo The 
implication of the low quality of the evidence is that further research on this topic is very 
likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. Therefore there is a great need for current best evidence on 
interventions for working with private for-profit healthcare providers to improve access and 
quality of health services. We plan to review the currently available evidence on public sector 
efforts to work with private for-profit health service providers to improve existing health 
services and expand and rationalise the coverage of these services.6 
B2. Objectives 
To assess the effects of public sector regulation, training, or coordination of health services 












B3.1. Criteria for considering studies for this review 
83.1.1. Types of studies 
The review includes: 
• Randomised controlled trials (RCTs) including individually-randomised and cluster-
randomised controlled trials 
• Non-randomised control trials 
o Controlled clinical trials (CCTs) 
o Interrupted time series designs (ITS) with at least three measurements before 
and after introducing the intervention 
o Controlled before-after studies (CBAs) with at least two intervention groups 
and at least two comparable control groups, with simultaneous data collection. 
B3.1.2. Types of participants 
Studies taking place in low and middle income countries as defined by the World Bank. All 
types of health services provided by for- profit providers will be included in our review. 
B3.1.3. Types of interventions 
Regulation, training, and coordination; of any intensity or duration, implemented by the 
public sector. The control must be a no-intervention or alternate-intervention group. 
Regulation refers to the setting and enforcing of standards for the private sector; training involves 
educating and supporting private service providers; and coordination entails organising and creating 
alliances among private and public healthcare providers. 
B3.1.4. Types of outcome measures 
B3.1.4.1.1. Primary outcomes 
• Quality of care (compliance with desired behaviour or guidance)' 











The following other outcomes of interest are included if reported in included studies: 
• Mortality or morbidity 
• Resource use· 
• Adverse effects (e.g. undesirable impacts on existing public or private services, 
inappropriate use of services, distortions in the provision of services) 
• Satisfaction of both health provider and patient 
• Attitudes of both health provider and patient 
B3.2. Search methods for identification of studies 
We searched the following electronic databases for primary studies: 
• The Cochrane Central Register of Controlled (CENTRAL), (10 Jan 2012) 
• MEDLINE In-Process & Other Non-Indexed Citations and MEDLINE, Ovid (1946 to 
present) (10 Jan 2012) 
• EMBASE, Ovid (from 1980 to 2012 week 03) (10 Jan 2012) 
• WHOLIS and WHO International Clinical Trials Platform (10 Jan 2012) 
• Science Citation Index Expanded (SCI-EXPANDED) (1975 to present) (10 Jan 2012) 
• Social Sciences Citation Index (SSCI) (1975 to present) (10 Jan 2012). 
In addition, we searched the Cochrane Database of Systematic Reviews (10 Jan 2012), and 
the Database of Abstracts of Reviews of Effectiveness (10 Jan 2012) for previous relevant 
reviews. We checked the reference lists of relevant previous reviews 1-6,47 and full-text 
articles reviewed for inclusion in this review. 
We developed a sensitive and previously validated search strategy for RCTs, non-RCTs, 
CBAs, and ITS studies combined with relevant MeSH and free-text terms relating to health 
regulation, training and coordination literature for low and middle-income countries. We 
placed no language or date restrictions on the search strategy. We translated the MEDLINE 











B3.3. Data collection and analysis 
B3.3.l. Selection of studies 
LA screened the titles and abstracts of outputs from the searches using the screening guide to 
identify studies which met the inclusion criteria and CW verified the selected records. We 
then retrieved all records deemed potentially eligible by at least one of the two authors, and 
discard the rest. LA obtained the full text of all potentially eligible articles, and LA and CW 
independently examined each of these for eligibility. Each of us compiled a list of studies 
which he/she believed met the inclusion criteria. Both authors compared the list and resolving 
discrepancies by discussion and consensus. 
B3.3.2. Data extraction and management 
Two authors (LA, CW) independently extracted descriptive and outcome data for each paper 
using a pre-designed data collection form. Both authors compared the list of included and 
excluded studies, resolving any discrepancies by discussion and consensus. (LA) entered the 
data into Review Manager (RevMan) 5.1. (CW) performed double checks in RevMan to 
ensure that there were no errors in the data entered. 
B3.3.3. Assessment of risk of bias in included studies 
We assessed the risk of bias based on six standard domains: 19 
• Sequence generation 
• Concealment of allocation 
• Blinded or objective assessment of primary outcome(s) 
• Incomplete outcome data 
• Selective outcome reporting 
• Other source of bias. 
For each included study, we reported our assessment of risk of bias for each domain i.e. low, 











judgment. The authors compared the results of their independent assessments of risk of bias 
and resolved any discrepancies by discussion and consensus. 
83.3.4. Measures of treatment effect 
We grouped measures of treatment effect based on outcome variables. For dichotomous 
outcomes, results from each trial were expressed as a risk ratio (RR) with 95% confidence 
intervals. Continuous outcomes were presented in several ways; when absolute values of 
post-intervention means and standard deviations (SD) were given, using the same rating 
across studies, we used these to calculate the mean difference (MD) and 95% confidence 
intervals. If different scales are used to measure the same outcomes, we calculated the 
standardised mean difference (SMD) with 95% confidence intervals and then combine these 
in a meta-analysis. 
B3.3.5. Unit of analysis issues 
Due to insufficient information available to control for clustering, we entered data into 
RevMan using individuals as the unit of analysis. We then performed sensitivity analyses to 
assess the potential bias that may have occurred as a result of the inadequately controlled 
clustered trials. 
B3.3.6. Dealing with missing data 
Where necessary, we contacted the corresponding authors of included studies to supply any 
unreported data but we did not get response. If a study reports outcomes only for participants 
completing the trial or only for participants who followed the protocol, we contacted the 
authors and ask them to provide additional information to permit us to conduct meta-analyses 
by intention-to-treat. We described missing data and dropouts for each included study in the 











B3.3. 7. Assessment of heterogeneity 
For those studies of similar interventions that report similar outcomes, we examined 
statistical heterogeneity between study results using the Chi2 test of homogeneity (with 
significance defined at the 10% alpha-level), and quantify any statistical heterogeneity 
between study results using the 12 statistic. 
B3.3.8. Data synthesis 
We analysed data using Review Manager 5. 11 We conducted meta-analysis when included 
randomised trials were similar in terms of participants, interventions, and outcomes. We 
pooled the data using random-effects method because we detected significant heterogeneity 
and considered it was clinically meaningful to combine the trials by intervention type. 
In addition, we used the GRADE approach to summarise the quality of the evidence on the 
effects on each outcome. 9 
00.3.9. Sensitivity analysis 
We planned to perform sensitivity analyses to explore the effect of risk of bias on the 
robustness of our findings. However, this was not possible because all the studies generally 












B4.1. Description of studies 
We obtained 7,629 titles and abstracts which were all in English language from the electronic 
search of 8 databases after which we removed 850 duplicates. We screened 6779 records of 
which 6746 were not relevant, thus we retrieved the full text of 33 potential eligible studies 
and reviewed for inclusion. Of these, 14 articles met our inclusion criteria 13,14,15,16,17,18,19, 
20,21,22,23,24,25,26 (see Table 1) and the remaining 19 were excluded with reasons as explained 
later (Table 2). A flow diagram of studies included in the analysis is shown in Figure 1 
below. 
Figure 1: Study flow diagram 
7629 records 
identined through 805 duplicates 
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B4.2. Included studies 
Fourteen studies on regulation and training of private-for-profit in low and middle income 
countries were included. Eleven were randomised control studies( 4 cluster randomised 
controlled trial and 7 individual randomised controlled trial, 13, 14, 16, 17, 18, 19,20,21,23,24,25 two 











Thirteen studies had interventions that concerned training; 13,14, IS, 16, 17,18, 19,20,21,22,23,24,26 
four studies assessed regulation 16,17,18,25 and no studies evaluated coordination. 
Intervention characteristic s 
Regulation 
Four studies evaluated regulation (N=4831 participants). 16,17,18,25 Of these, one study 25 
evaluated only regulation (N=92) while the other three 16,17,18 had a multi-faceted 
intervention (N=4739 participants), consisting of regulation, training and peer 
review/influence. 
The regulatory intervention in Lao Peoples Democratic Republic involved intensive 
supervision of the quality of pharmacy services, applying sanctions when rules were violated, 
and providing up-to-date regulatory documents and information about particular areas 
needing improvements. 25 The study compared districts with active regulation districts 
compared to districts with no intervention. As indicated earlier, the other three studies 16,17,18 
evaluated a multi-faceted intervention which involved regulation, training and peer review. 
Each intervention lasted three months, with a gap of four months before the next intervention. 
Two studies 16 18 were performed in Hanoi, Vietnam while one study 17 was performed in 
Hanoi, Vietnam and Bangkok, Thailand. The studies compared districts with multi-faceted 
intervention to districts with no intervention as control. All pharmacists who received 
multifaceted intervention received all three interventions as a set. Enforcement regulation was 
performed by pharmacy inspectors while training interventions assessed educational visits by 
senior researchers. Peer review/ influence consisted of using group leaders and 
representatives of the pharmacy association as opinion leaders to influence practice. 
Training 
Thirteen studies 13,14, IS, 16, 17, 18, 19,20,21,22,23,24,26 evaluated training (N=8925 participants). Of 
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! studies 16,17,18 had a multifaceted intervention (N =311 participants/ 4445 encounters) which 
combined training with regulation and peer review/influence. 
Training covered different types of private providers: three targeted private doctors, 14, 15,22 
six targeted private pharmacy workers/drug retailers, 13,16,17,18,21,24 one targeted private 
dentists 19 and three targeted a mix of provider types. 20, 23,26 Training aimed to improve the 
quality of care of a range of different conditions; six studies focused on treatment of 
childhood illness, 13, 15, 16,21,22,24 three studies addressed quality of sexually transmitted 
infection (STI) treatment 18,20,23, two studies assessed dispensing of antibiotics 17,26 and the 
remaining two studies addressed other health issue. 14,19 
Coordination 
We did not identify an eligible study that assessed coordination of private-for-profit 
providers. 
Outcome characteristics 
Various kinds of indicators reported in each study can be seen in Table 1 below but these 
were broadly categorized as quality of care. All 14 included studies 13,14, IS, 16, 17, 18, 19,20,21,22, 












Table 1: Characteristics of incluMd studies 
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84.3. ":a:cluded studies 
Nineteen studies 27. 2J, 29, 3<1, 31,32. 13, J4, 3.'. 36, n J!, )9, 4~ , 41 , 42, 4J, 44, 4j were excluded for reasons 
gIven III Table 2 he/ow, The most common reason for el<c1usion was au iu elib>ible study 
design. 
Table 2; Charact~ristic~ (If ~xc1udcd studic~ 
OUT judgements on the risk of bias in each included study are summarised in Fig 2& 3 below. 
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Fixurc 3: Risk of bias summary 
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B4.4.1. Sequence ~eneration and allocation concealment (selection bias) 
The generation of the randomization sequence was adequate in three studies, 14, 20, 21 
inadequate in two Il, n and unclear in the remaining nine. IJ. I';. 17. 19.23 . 24, 2S. 11.26. The 
allocation concealment was adequate in one study 10 and unclear in all the others. 1).14, Il. 1-. 
B4.4.2. Blinding (performance bia~ and detection bia~) 
() bl ' d d' I --~. 112(U" lbl'd' d' utcome assCsSOrs werc m c m our StllU1CS; , ., m mg was not OnC In one 










B4.4.3. Incomplete outcome data (attrition bias) 
Loss to follow up was minimal in one study 23 and moderate to high in the rest 13,15,17,18,22,14, 
16,19,20,21,24,25,26 
B4.4.4. Selective reporting (reporting bias) 
Selective reporting was categorized as unclear since the study protocols were not available. 
B4.4.5. Other potential sources of bias 
In one study (a cluster randomised controlled trial) there was some degree of contamination 
in a district which was meant to be a control district. We did not have any evidence that other 
biases were introduced into the remaining studies, over and above the ones reported above. 
B4.5. Effects of interventions 
Primary outcome 
Quality of care 
Fourteen studies reported measmes of quality of care, such as correct management of 
diseases. The results were pooled based on intervention and study design. 
Training: There were 12 studies on training which were sub-grouped by type of study design. 
The pooled results show no evidence of an effect for individually randomised controlled 
trialsl4,I6, 17,19, 23, 24 (6 studies, 2956 participants, RR 0.99,95% CI 0.70 to 1.39,12=96%; 
figme 4a), controlled clinical trials26 (1 study, 171 participants, RR 0.89,95% CI 0.74 to 
1.06; figme 4e), and controlled before and after studies (2 studies, 199 participants, RR 1.37, 
95% CI 0.81 to 2.33, 12=0%; figme 4d). 15,22 However, cluster randomised controlled trials 
13,20, 21 show significant beneficial effects on quality of care among those who received 
training compared to those were not offered training (3 studies, 1154 participants, RR 3.07, 
95% CI 1.55 to 6.08, 12=91 %; figme 4b). In addition, one cluster randomised controlled trial 











mean difference 0.16 CI 0.10 to 0.21; ligur~ 4c) .. Using the Gr4d~ approach. ! W~ judged the 
quality of ~videnee on the effects of training on quality of care as moderate (GRADE 
summary of linding~ table avui luble in appendix B. 7. 1 ). 
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Fi~urt 4c: Meta analys is of continuons cluster randomised controlled trial of training 
inten'entions un quali!)' of care. 
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Summary of main results 
We identified 7629 studies from the electronic search, 33 of which were potentially eligible. 
We excluded 19 of these studies because they were descriptive in nature and did not involve a 
rigorous evaluation of training, regulation or coordination of private for-profit healthcare 
providers. The remaining 14 studies met our inclusion criteria. Thirteen studies assessed 
training, four assessed regulation and none assessed coordination. These studies generally 
had a high risk of bias. Seven of the 13 studies on training interventions were carried out in 
Africa and the rest in Asia. These studies evaluated a range of private for-profit services from 
pharmaceutical practices to prescribing practices. All four studies on regulation were carried 
out in Asia i.e. Vietnam (2 studies), Thailand, and Lao; and they mostly targeted private for-
profit pharmacy practices. The pooled results show that training probably improves the 
quality of care. However, our findings do not rule out a beneficial or harmful effect of 
regulation on quality of care. We did not identify an eligible study on coordination of private 
for profit providers. None of the studies reported data on our secondary outcomes (mortality 
or morbidity, resource use, adverse effects, satisfaction, or attitudes). 
Overall completeness and applicability of evidence 
During literature search despite the large number of records obtained, only 14 studies with a 
high risk of bias met our inclusion criteria. All studies were conducted in the low and middle 
income countries. It is evident that these interventions have worked successfully in low and 
middle income countries thus the results are applicable to the context of low- and middle-
income countries. Most of the studies covered pharmaceutical and prescribing practices; 
therefore there is a need for studies on other aspects of private for profit of health care. The 
absence of data on secondary outcomes such as altitude and satisfaction may suggest that 











outcomes. Using the GRADE approach, 8 we judged the quality of evidence on the effects of 
training on quality of care as moderate, which implies that "further research is likely to have 
an important impact on our confidence in the estimate of effect and may change the 
estimate". The quality of the evidence on regulatory interventions is considered as low 
quality evidence which means the "further research is very likely to have an important impact 
on our confidence in the estimate of effect and is likely to change the estimate". 8 
Potential biases in the review process 
We minimised potential biases in the review process by adhering to the guidelines of the 
Cochrane Collaboration. 12 We conducted comprehensive searches without limiting the 
searches to a specific language. Two independent authors assessed study eligibility, extracted 
data, and assessed the risk of bias in each included study. In addition, we sub-grouped 
analysis by intervention and study design. 
Agreement with other studies or reviews 
The findings of our review are consistent with those of two related previous reviews. 4, 6 
Both found limited evidence on the effects of public stewardship interventions such as 
training and regulation. However, to the best of our knowledge, our review is the most 
comprehensive and up-to-date assessment of the evidence on the effects of training, 
regulation and coordination of private for-profit health care in low- and middle- income 
countries. Our review includes six additional studies, 13, 14, 19,20,21,22 over and above the ones 
included in the two previous reviews. 4, 6 
Conclusion 
Currently available evidence shows that training probably improves quality of health care in 
the by private for-profit sector. However, the currently available evidence does not rule out a 
beneficial or harmful effect of regulation on the quality of care provided by the private for-











intervention are needed. We recommend that further research on the interventions assessed in 
this review should be of high quality and should assess other policy-relevant outcomes such 
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Governments have the responsibility to provide basic health services. However, the public 
sector does not provide high quality health services accessible to all. This explains why 
private sector plays a major role but the health care provided is not always of high quality. 
Therefore, there is a need for public-private sector collaboration in order to increase access to 
quality services. We assessed the effects of public sector regulation, training, or coordination 
of health services provided by the private for-profit sector in low and middle-income 
countries. 
Methods: In Jan 2012, we searched the Cochrane Central Register of Controlled, Medline, 
EMBASE, WHO Library Information System, Web of science, Database of Abstracts of 
Reviews of Effectiveness, Cochrane Database of Systematic Reviews, and the WHO Clinical 
Trials Platform .We identified randomised controlled trials (RCTs) and non-randomised 
control trials (non-RCT) which includes Controlled clinical trials (CCTs), Interrupted time 
series designs (ITS) and Controlled before-after studies (CBAs) with regulation, training and 
coordination intervention low and middle income countries. The effects of interventions are 
compared using risk ratios (RR) or Mean difference, and presented with 95% confidence 
intervals (CI). The quality of the evidence was assessed using GRADE. 
Findings: We identified 7629 studies from the electronic search, 33 of which were 
potentially eligible. We excluded 19 of these studies because they were descriptive in nature 
and did not involve a rigorous evaluation of training, regulation, or coordination of private 
for-profit hea1thcare providers. The remaining 14 studies met our inclusion criteria: six 
individual randomised controlled trials, three clusters randomised controlled trials, two 
controlled before and after studies and one controlled clinical trial. Thirteen studies assessed 
training, four assessed regulation, and none assessed coordination. These studies generally 










Seven of the 13 studies on training were carried out in Africa and the rest in Asia. These 
studies evaluated a range of private for profit services from phannaceutical practices to 
prescribing practices. All the four studies on regulation were carried out in Asia i.e. Vietnam 
(2 studies), Thailand and Lao. They mostly targeted private for-profit phannacy practices. 
The pooled results show no evidence of an effect for individually randomised controlled trials 
(6 studies, 2956 participants, RR 0.99,95% CI 0.70 to 1.39,12=96%), controlled clinical 
trials (1 study, 171 participants, RR 0.89, 95% CI 0.74 to 1.06), and controlled before and 
after studies (2 studies, 199 participants, RR 1.37,95% CI 0.81 to 2.33,12=0%). However, 
cluster randomised controlled trials show significant beneficial effects on quality of care 
among those who received training compared to those were not offered training (3 studies, 
1154 participants, RR 3.07,95% CI 1.55 to 6.08, 12=91 %). In addition one cluster 
randomised controlled trial that reported continuous data also shows a beneficial effect of 
training (1 study, N=4445, mean difference 0.16 CI 0.10 to 0.21). The pooled results of 
regulation do not rule out either a beneficial or harmful effect on quality of care (2 studies, 
306 participants, RR 1.05,95% CI 0.81 to 1.37,12=49%). The remaining two studies reported 
continuous data; one cluster randomised controlled trial shows a small beneficial effect (1 
study, N=4445, mean difference -0.07, CI -0.13 to -0.01) while the other study, an individual 
randomised controlled trial did not show any evidence of effect (1 study, N=92, mean 
difference 0.07, CI -0.34 to -0.48). We did not find an eligible study on coordination. None 
of the studies reported data on mortality or morbidity, resource use, adverse effects, 
satisfaction, or attitudes. 
Conclusions: Currently available evidence shows that training probably improves quality of 
health care in the by private for-profit sector. However, the currently available evidence does 
not rule out a beneficial or harmful effect of regulation on the quality of care provided by the 











studies on this intervention are needed. We recommend that further research on the 
interventions assessed in this review should be of high quality and should assess other policy-














Governments have the responsibility to provide basic services, including health care, to their 
citizens. However, the public sector is not sufficiently well-equipped and financed to provide 
high quality health services that are accessible to all. I This explains why private healthcare 
providers playa major role in health service provision in many low and middle-income 
countries.2-6 Given the need to work with the private sector to increase access to services, 
various strategies have been proposed that governments can employ to engage the private 
sector in service provision.6 These include regulation, contracting, financing and social 
marketing, training, and coordination. I, 6 These interventions are generally applied in 
combination to reach two important goals: (1) improving the quality of care delivered by 
existing service providers; and (2) expanding the coverage of private sector services and 
rationalising this coverage with that of public sector providers. 6 However, there is a paucity 
of systematic reviews on the effects of these interventions on the quality and accessibility of 
private for-profit health care in low and middle-income countries. I, 2, 6 We therefore initiated 
this review to assess the public stewardship of the private for-profit health sector in low and 
middle-income countries. 
Scarce government resources in low and middle-income countries have led to a decline in the 
quantity and quality of public health services.2,31,4,6 These public health failures have led to a 
drastic increase in private providers of health services, both for-profit and not-for profit, in 
many low and middle-income countries. I-6, 10,31,32 The consequence of this expansion in the 
private health sector is that (poor) communities spend outsized amounts of money for private 
health services; at times when cheaper public sector alternatives are available.3, 4, 6 However, 
the suitability and quality of the services provided by the private health sector is increasingly 











Public stewardship refers to government policies, regulatory mechanisms and implementation 
strategies for ensuring guidance and accountability.lO We will focus on three types of 
strategic interventions, namely, regulation, training, and coordination excluding potential 
interventions which are already covered by systematic reviews published in the last three 
years; such as social marketing and franchising, 27 contracting, 29 and pay for performance.30 
Regulation refers to the setting and enforcing of standards for the private sector; training 
involves educating and supporting private service providers; and coordination entails 
organising and creating alliances among private and public sector healthcare providers. 
A systematic review published in 2007 found "evidence that effective pUblic-private 
partnerships can increase access, improve equity, and raise quality of health services". 4 
However, using the GRADE approach, 8,9 this evidence on the effectiveness of interventions 
for working with the private for-profit sector to improve the utilisation and quality of health 
services for the poor in the low and middle-countries was found to be of low quality .10 The 
implication of the low quality of the evidence is that further research on this topic is very 
likely to have an important impact on our confidence in the estimate of effect and is likely to 
change the estimate. Therefore there is a great need for current best evidence on 
interventions for working with private for-profit healthcare providers to improve access and 
quality of health services. 
We did a systematic review to assess the effects of public sector regulation, training, or 













C2.t. Search strategy and selection criteria 
We included only randomised controlled trials (RCTs) and non-randomised control trials 
which includes Controlled clinical trials (CCTs), Interrupted time series designs (ITS) and 
Controlled before-after studies (CBAs). Eligible studies were conducted in low and middle 
income countries as defined by the World Bank. All types of health services provided by for-
profit providers were considered. Eligible interventions were regulation, training, and 
coordination; of any intensity or duration, implemented by the public sector. The control had 
to be a no-intervention or alternate-intervention group. Our primary outcome was quality of 
care (defined as compliance with desired behaviour or guidance). Our secondary outcomes 
were mortality or morbidity, cost of implementing the interventions, adverse effects, 
satisfaction, and attitudes to both health providers and patients. 
We searched the following electronic databases for primary studies on 10 January 2012: 











Information System; WHO International Clinical Trials Platform; Science Citation Index 
Expanded; and Social Sciences Citation Index. In addition, on the same date, we searched the 
Cochrane Database of Systematic Reviews, and the Database of Abstracts of Reviews of 
Effectiveness for previous relevant reviews. We checked the reference lists of relevant 
previous reviews 1-6,28 and full-text articles reviewed for inclusion in this review. We placed 
no language or date restrictions on the search strategy. The search strategy is included in 
section C6 Appendix 1. LA screened the titles and abstracts of outputs from the searches 
using the screening guide to identify studies which met the inclusion criteria and CW verified 
the selected records. We then retrieved all records deemed potentially eligible by at least one 
of the two authors, and discard the rest. LA obtained the full text of all potentially eligible 
articles, and LA and CW independently examined each of these for eligibility. Each of us 
compiled a list of studies which he/she believed met the inclusion criteria. Both authors 
compared the list and resolved discrepancies by discussion and consensus. 
C2.2. Data collection and analysis 
We assessed the risk of bias based on six standard domains: 12 sequence generation, 
concealment of allocation, blinded or objective assessment of primary outcome(s), 
incomplete outcome data, selective outcome reporting and other source of bias. 
For each included study, we reported our assessment of risk of bias for each domain (i.e. low, 
high and unclear) together with a descriptive summary of the information that influenced our 
judgment. The authors compared the results of their independent assessments of risk of bias 
and resolved any discrepancies by discussion and consensus. 
Two authors (LA, CW) independently extracted descriptive and outcome data for each paper 
using a pre-designed data collection form. Both authors compared the list of included and 
excluded studies, resolving any discrepancies by discussion and consensus. LA entered the 











RevMan to ensure that there were no errors in the data entered. We grouped measures of 
treatment effect based on outcome variables. For dichotomous outcomes, results from each 
trial were expressed as a risk ratio (RR) with 95% confidence intervals. Continuous outcomes 
were presented in several ways; when absolute values of post-intervention means and 
standard deviations (SD) were given, using the same rating across studies, we used these to 
calculate the mean difference (MD) and 95% confidence intervals. If different scales are used 
to measure the same outcomes, we calculated the standardised mean difference (SMD) with 
95% confidence intervals and then combine these in a meta-analysis. We analysed data using 
Review Manager 5 11• We conducted meta-analysis when included randomised trials were 
similar in tenns of participants, interventions, and outcomes. We pooled the data using 
random-effects method because we detected significant heterogeneity and considered it was 
clinically meaningful to combine the trials by intervention type and study design. We planned 
to perfonn sensitivity analyses to explore the effect of risk of bias on the robustness of our 
findings. However, this was not possible because all the studies generally had a high risk of 
bias. In addition, we used the GRADE approach to summarise the quality of the evidence on 
the effects on each outcome. 9 
Role of funding source 
There was no specific funding source for this study. LA and CW had full access to the data 












We obtained 7,629 titles and abstracts which were all in English language from the electronic 
search of8 databases after which we removed 850 duplicates. We screened 6779 records of 
which 6746 were not relevant, thus we retrieved the full text of33 potential eligible studies 
and reviewed for inclusion. Of these, 14 articles met our inclusion criteria 13,14,15,16,17,18,19, 
20,21,22,23,24,25,26 (see Table 1) and the remaining 19 were excluded with reasons as explained 
later (Table 2). A flow diagram of studies included in the analysis is shown in Figure 1 
below. 
Figure 1: Study flow diagram 
7629 records 
identified through 805 duplicates 
database removed 
searching 
6779 records 6746 records 
screened excluded 
19 full-text articles 




Fourteen studies on regulation and training of private-for-profit in low and middle income 
countries were included. Eleven were randomised control studies( 4 cluster randomised 
controlled trial and 7 individual randomised controlled trial, 13,14,16,17,18,19,20,21,23,24,25 two 
controlled before and after studies, 15,22 and one controlled clinical trial.26 Thirteen studies 
had interventions that concerned training; 13,14,15,16,17,18,19,20,21,22,23,24,26 four studies 
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not have any evidence that other biases were introduced into the remaining studies, over and 
above the ones reported above. 
Fourteen studies reported measures of quality of care, such as correct management of 
diseases. The results were pooled based on intervention and study design. Training: There 
were 12 studies on training which were sub-grouped by type of study design. The pooled 
results show no evidence of an effect for individually randomised controlled trials14, 16, 17, 19, 
23,24 (6 studies, 2956 participants, RR 0.99,95% CI 0.70 to 1.39,12=96%; figure 3a), 
controlled clinical trials26 (1 study, 171 participants, RR 0.89,95% CI 0.74 to 1.06; figure 
3e), and controlled before and after studies (2 studies, 199 participants, RR 1.37, 95% CI 0.81 
to 2.33, 12=0%; figure 3d). 15,22 However, cluster randomised controlled trials 13,20,21 show 
significant beneficial effects on quality of care among those who received training compared 
to those were not offered training (3 studies, 1154 participants, RR 3.07,95% CI 1.55 to 6.08, 
12=91 %; figure 3b). In addition, one cluster randomised controlled trial 18 that reported 
continuous data also shows a beneficial effect of training (1 study, N=4445, mean difference 
0.16 CI 0.10 to 0.21; figure 3c). Using the Grade approach, 8 we judged the quality of 
evidence on the effects of training on quality of care as moderate (GRADE summary of 











Figure 3a: Meta analysis of individual randomised controlled trial of training 
intenentions on qual ity of care. 
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Figure 3b: Meta analysis of cluster randnmised cnntrolled trial of training intenentions 
On quality of care. 
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Figure 3c: Meta analysis of continunus cluster randomised controlled trial oflraining 
interventions nn quality of care. 
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Figur~ 3d: Md .. Im .. I)'~i~ of cnntroiled befnre and after nftraining interventinn nn 
quality nf care. 
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Fignre 3e: Meta analysis nf enntrnlled clinical trials nf training interventinn nn quality 
of c .. re. 
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Regulation: In fhur studies, regulation of distribution and selling of registered pharmacelltical 
products was compared to no intervention. The Tegulation aimed to protect consumers against 
unfuir practices. The pooled results to, n do not rule out either a beneficial or harmful effect 
()f regulation on qwlity of care (2 studies, 306 participants, RR LOS, 95% CI 0.81 to 1.37, 
1'=49%; figure 4a). The remaining two studies reported continuous data; one cluster 
randomiscd controlled trial" sbows a smallbcneficial effect (I study, N=4445, mean 
difference -0.07, Cl -0.13 to -0.01; figure 4b) while the individually randomiscd controlled 
triaf' did not find evidence of an effect (I study, N=92, mean difference 0.07, Cl-O.34 to -
0.48; figure 4c). We categorised the quality of the evidence on regulatory interventions as 
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Figure 3b: Meta analysis of continuous clustcr randomiscd controllcd trial of 
Re~ulatioD int~n'~ntion on qunlit), of care. 
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We identified 7629 studies from the electronic search, 33 of which were potentially eligible. 
We excluded 19 of these studies because they were descriptive in nature and did not involve a 
rigorous evaluation of training, regulation or coordination of private for-profit healthcare 
providers. The remaining 14 studies met our inclusion criteria. Thirteen studies assessed 
training, four assessed regulation and none assessed coordination. These studies generally 
had a high risk of bias. Seven of the 13 studies on training interventions were carried out in 
Africa and the rest in Asia. These studies evaluated a range of private for-profit services from 
pharmaceutical practices to prescribing practices. All four studies on regulation were carried 
out in Asia i.e. Vietnam (2 studies), Thailand, and Lao; and they mostly targeted private for-
profit pharmacy practices. The pooled results show that training probably improves the 
quality of care. However, our findings do not rule out a beneficial or harmful effect of 
regulation on quality of care. We did not identify an eligible study on coordination of private 
for profit providers. None of the studies reported data on our secondary outcomes (mortality 
or morbidity, resource use, adverse effects, satisfaction, or attitudes). 
During literature search despite the large number of records obtained, only 14 studies with a 
high risk of bias met our inclusion criteria. All studies were conducted in the low and middle 
income countries. It is evident that these interventions have worked successfully in low and 
middle income countries thus the results are applicable to the context of low- and middle-
income countries. Most of the studies covered pharmaceutical and prescribing practices; 
therefore there is a need for studies on other aspects of private for profit of health care. The 
absence of data on secondary outcomes such as altitude and satisfaction may suggest that 
quantitative studies have not adequately evaluated the effects of interventions on these 
outcomes. Using the GRADE approach, 8 we judged the quality of evidence on the effects of 











an important impact on our confidence in the estimate of effect and may change the 
estimate". The quality of the evidence on regulatory interventions is considered as low 
quality evidence which means the "further research is very likely to have an important impact 
on our confidence in the estimate of effect and is likely to change the estimate". 8 
We minimised potential biases in the review process by adhering to the guidelines of the 
Cochrane Collaboration. 12 We conducted comprehensive searches without limiting the 
searches to a specific language. Two independent authors assessed study eligibility, extracted 
data, and assessed the risk of bias in each included study. In addition, we sub-grouped 
analysis by intervention and study design. 
The findings of our review are consistent with those of two related previous reviews. 4, 6 
Both found limited evidence on the effects of public stewardship interventions such as 
training and regulation. However, to the best of our knowledge, our review is the most 
comprehensive and up-to-date assessment of the evidence on the effects of training, 
regulation and coordination of private for-profit health care in low- and middle- income 
countries. Our review includes six additional studies, 13, 14, 19,20,21,22 over and above the ones 
included in the two previous reviews. 4, 6 
Currently available evidence shows that training probably improves quality of health care in 
the by private for-profit sector. However, the currently available evidence does not rule out a 
beneficial or harmful effect of regulation on the quality of care provided by the private for-
profit sector. We found no data on the effects of coordination, thus rigorous studies on this 
intervention are needed. We recommend that further research on the interventions assessed in 
this review should be of high quality and should assess other policy-relevant outcomes such 
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C6.1. Search strategy 
1. CENTRAL (Cochrane Library) 
# Searches 
#1 MeSH descriptor Public-Private Sector Partnerships, this term only 
#2 MeSH descriptor Private Sector, this term only 
#3 MeSH descriptor Private Practice, this term only 
#4 MeSH descriptor Hospitals, Private, this term only 
#5 MeSH descriptor Privatization, this term only 
#6 privat* :ti,ab 
#7 MeSH descriptor Public Sector, this term only 
#8 MeSH descriptor Public Policy, this term only 
#9 MeSH descriptor Health Policy, this term only 
#10 MeSH descriptor State Dentistry, this term only 
# 11 MeSH descriptor Health Care Reform, this term only 
# 12 MeSH descriptor Health Planning, this term only 
#13 MeSH descriptor Social Control, Formal, this term only 
#14 MeSH descriptor Law Enforcement, this term only 
#15 MeSH descriptor Government explode all trees 
#16 MeSH descriptor Government Regulation, this term only 
#17 MeSH descriptor Facility Regulation and Control, this term only 
# 18 MeSH descriptor Policy Making, this term only 
#19 MeSH descriptor Jurisprudence, this term only 
#20 MeSH descriptor Mandatory Reporting, this term only 
#21 MeSH descriptor Politics, this term only 
#22 MeSH descriptor Legislation as Topic, this term only 
#23 MeSH descriptor Legislation, Hospital, this term only 
#24 MeSH descriptor Legislation, Medical, this term only 
#25 MeSH descriptor Legislation, Nmsing, this term only 
#26 MeSH descriptor Legislation, Pharmacy, this term only 
#27 MeSH descriptor Legislation, Drug, this term only 
#28 MeSH descriptor Legislation, Dental, this term only 
#29 (public* or stewardship* or governance or governing or coordinat* or co NEXT 
ordinat* or legislat* or regulat* or government* or law or laws or act or acts or policy or 
policies or politics or reform* or control* or supervis* or monitor*):ti,ab 
#30 MeSH descriptor Physician's Practice Patterns, this term only 
#31 MeSH descriptor Nmse's Practice Patterns, this term only 
#32 MeSH descriptor Dentist's Practice Patterns, this term only 











#34 MeSH descriptor Malpractice, this term only 
#35 MeSH descriptor Professional Impairment, this term only 
#36 MeSH descriptor Physician Impairment, this term only 
#37 MeSH descriptor Medical Errors, this term only 
#38 MeSH descriptor Diagnostic Errors, this term only 
#39 MeSH descriptor Medication Errors explode all trees 
#40 MeSH descriptor Professional Competence, this term only 
#41 MeSH descriptor Clinical Competence, this term only 
#42 (competence or practice NEXT pattern· or malpractice or mal NEXT practice or 
error·):ti,ab 
#43 MeSH descriptor Education, this term only 
#44 MeSH descriptor Competency-Based Education, this term only 
#45 MeSH descriptor Education, Public Health Professional, this term only 
#46 MeSH descriptor Education, Medical, this term only 
#47 MeSH descriptor Education, Medical, Continuing, this term only 
#48 MeSH descriptor Education, Nursing, this term only 
#49 MeSH descriptor Education, Nursing, Continuing, this term only 
#50 MeSH descriptor Education, Dental, this term only 
#51 MeSH descriptor Education, Dental, Continuing, this term only 
#52 MeSH descriptor Education, Pharmacy, this term only 
#53 MeSH descriptor Education, Pharmacy, Continuing, this term only 
#54 (educat· or train or training or trained or colloquium· or conference· or course· or 
lecture· or meeting· or seminar· or support· or symposi· or workshop·):ti,ab 
#55 MeSH descriptor Delivery of Health Care, this term only 
#56 MeSH descriptor Quality of Health Care, this term only 
#57 MeSH descriptor Quality Assurance, Health Care, this term only 
#58 MeSH descriptor Quality Improvement, this term only 
#59 MeSH descriptor Total Quality Management, this term only 
#60 MeSH descriptor Outcome and Process Assessment (Health Care), this term only 
#61 MeSH descriptor Outcome Assessment (Health Care), this term only 
#62 MeSH descriptor Process Assessment (Health Care), this term only 
#63 MeSH descriptor Guideline Adherence, this term only 
#64 MeSH descriptor Benchmarking, this term only 
#65 MeSH descriptor Standard of Care, this term only 
#66 MeSH descriptor Reference Standards, this term only 
#67 (best NEXT practice or quality or standard· or benchmark· or adherence or 
requirement·):ti,ab 
#68 (Africa or Asia or Caribbean or "West Indies" or "South America" or "Latin America" or 
"Central America"):ti,ab,kw 
#69 (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 











Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or "Burkina Faso" or "Burkina Fasso" or "Upper Volta" or Burundi or Urundi or 
Cambodia or "Khmer Republic" or Kampuchea or Cameroon or Cameroons or Cameron 
or Camerons or "Cape Verde" or "Central African Republic" or Chad or Chile or China 
or Colombia or Comoros or "Comoro Islands" or Comores or Mayotte or Congo or Zaire 
or "Costa Rica" or "Cote d'Ivoire" or "Ivory Coast" or Croatia or Cuba or Cyprus or 
Czechoslovakia or "Czech Republic" or Slovakia or "Slovak Republic"):ti,ab,kw 
#70 (Djibouti or "French Somaliland" or Dominica or "Dominican Republic" or "East Timor" 
or "East Timur" or "Timor Leste" or Ecuador or Egypt or "United Arab Republic" or "EI 
Salvador" or Eritrea or Estonia or Ethiopia or Fiji or Gabon or "Gabonese Republic" or 
Gambia or Gaza or Georgia or Georgian or Ghana or "Gold Coast" or Greece or Grenada 
or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary 
or India or Maldives or Indonesia or Iran or Iraq or "Isle of Man" or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or "Kyrgyz Republic" or Kirghiz or Kirgizstan or "Lao PDR" or Laos or Latvia 
or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,kw 
#71 (Macedonia or Madagascar or "Malagasy Republic" or Malaysia or Malaya or Malay or 
Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or "Marshall Islands" or 
Mauritania or Mauritius or "Agalega Islands" or Mexico or Micronesia or "Middle East" 
or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni 
or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or "Netherlands 
Antilles" or "New Caledonia" or Nicaragua or Niger or Nigeria or "Northern Mariana 
Islands" or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or 
Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or 
"Puerto Rico"):ti,ab,kw 
#72 (Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or "Saint 
Kitts" or "St Kitts" or Nevis or "Saint Lucia" or "St Lucia" or "Saint Vincent" or "St 
Vincent" or Grenadines or Samoa or "Samoan Islands" or "Navigator Island" or 
''Navigator Islands" or "Sao Tome" or "Saudi Arabia" or Senegal or Serbia or 
Montenegro or Seychelles or "Sierra Leone" or Slovenia or "Sri Lanka" or Ceylon or 
"Solomon Islands" or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria 
orT~ikistanorT~stanorTadjikistanorTadzhikorTanzaniaorThailandorTogo 
or "Togolese Republic" or Tonga or Trinidad or Tobago or Tunisia or Turkey or 
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or "Soviet Union" 
or "Union of Soviet Socialist Republics" or Uzbekistan or Uzbek or Vanuatu or "New 
Hebrides" or Venezuela or Vietnam or "Viet Nam" or "West Bank" or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia):ti,ab,kw 
#73 (developing or less· NEXT developed or "under developed" or underdeveloped or 
"middle income" or low· NEXT income or underserved or "under served" or deprived or 
poor·) NEXT (countr· or nation· or population· or world):ti,ab,kw 
#74 (developing or less· NEXT developed or "under developed" or underdeveloped or 
"middle income" or low· NEXT income) NEXT (economy or economies):ti,ab,kw 
#75 low· NEXT (gdp or gnp or "gross domestic" or "gross national"):ti,ab,kw 
#76 (low NEARl3 middle NEARl3 countr·):ti,ab,kw 
#77 (lmic or lmics or "third world" or "lami country" or "lami countries"):ti,ab,kw 











#79 (#2 OR #3 OR #4 OR #5 OR #6) 
#80 (#7 OR #8 OR#9 OR #10 OR #11 OR#12 OR #13 OR#14 OR#15 OR#16 OR#17 
OR #18 OR #19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR 
#28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 
OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR 
#49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 
OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67) 
#81 (#68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR 
#78) 
#82 (#1 AND #81) 
#83 (#79 AND #80 AND #81) 
#84 (#82 OR #83) 
2. DARE (Cochrane Library) 
# Searches 
#1 MeSH descriptor Public-Private Sector Partnerships, this term only 
#2 MeSH descriptor Private Sector, this term only 
#3 MeSH descriptor Private Practice, this term only 
#4 MeSH descriptor Hospitals, Private, this term only 
#5 MeSH descriptor Privatization, this term only 
#6 privat* :ti,ab 
#7 MeSH descriptor Public Sector, this term only 
#8 MeSH descriptor Public Policy, this term only 
#9 MeSH descriptor Health Policy, this term only 
#10 MeSH descriptor State Dentistry, this term only 
# 11 MeSH descriptor Health Care Reform, this term only 
#12 MeSH descriptor Health Planning, this term only 
#13 MeSH descriptor Social Control, Formal, this term only 
#14 MeSH descriptor Law Enforcement, this term only 
# 1 5 MeSH descriptor Government explode all trees 
#16 MeSH descriptor Government Regulation, this term only 
#17 MeSH descriptor Facility Regulation and Control, this term only 
#18 MeSH descriptor Policy Making, this term only 
#19 MeSH descriptor Jurisprudence, this term only 
#20 MeSH descriptor Mandatory Reporting, this term only 
#21 MeSH descriptor Politics, this term only 
#22 MeSH descriptor Legislation as Topic, this term only 
#23 MeSH descriptor Legislation, Hospital, this term only 
#24 MeSH descriptor Legislation, Medical, this term only 
#25 MeSH descriptor Legislation, Nursing, this term only 
#26 MeSH descriptor Legislation, Pharmacy, this term only 











#28 MeSH descriptor Legislation, Dental, this term only 
#29 (public· or stewardship· or governance or governing or coordinat· or co NEXT 
ordinat· or legislat· or regulat· or government· or law or laws or act or acts or policy or 
policies or politics or reform· or control· or supervis· or monitor·):ti,ab 
#30 MeSH descriptor Physician's Practice Patterns, this term only 
#31 MeSH descriptor Nurse's Practice Patterns, this term only 
#32 MeSH descriptor Dentist's Practice Patterns, this term only 
#33 MeSH descriptor Health Knowledge, Attitudes, Practice, this term only 
#34 MeSH descriptor Malpractice, this term only 
#35 MeSH descriptor Professional Impairment, this term only 
#36 MeSH descriptor Physician Impairment, this term only 
#37 MeSH descriptor Medical Errors, this term only 
#38 MeSH descriptor Diagnostic Errors, this term only 
#39 MeSH descriptor Medication Errors explode all trees 
#40 MeSH descriptor Professional Competence, this term only 
#41 MeSH descriptor Clinical Competence, this term only 
#42 (competence or practice NEXT pattern· or malpractice or mal NEXT practice or 
error·):ti,ab 
#43 MeSH descriptor Education, this term only 
#44 MeSH descriptor Competency-Based Education, this term only 
#45 MeSH descriptor Education, Public Health Professional, this term only 
#46 MeSH descriptor Education, Medical, this term only 
#47 MeSH descriptor Education, Medical, Continuing, this term only 
#48 MeSH descriptor Education, Nursing, this term only 
#49 MeSH descriptor Education, Nursing, Continuing, this term only 
#50 MeSH descriptor Education, Dental, this term only 
#51 MeSH descriptor Education, Dental, Continuing, this term only 
#52 MeSH descriptor Education, Pharmacy, this term only 
#53 MeSH descriptor Education, Pharmacy, Continuing, this term only 
#54 (educat· or train or training or trained or colloquium· or conference· or course· or 
lecture· or meeting· or seminar· or support· or symposi· or workshop·):ti,ab 
#55 MeSH descriptor Delivery of Health Care, this term only 
#56 MeSH descriptor Quality of Health Care, this term only 
#57 MeSH descriptor Quality Assurance, Health Care, this term only 
#58 MeSH descriptor Quality Improvement, this term only 
#59 MeSH descriptor Total Quality Management, this term only 
#60 MeSH descriptor Outcome and Process Assessment (Health Care), this term only 
#61 MeSH descriptor Outcome Assessment (Health Care), this term only 
#62 MeSH descriptor Process Assessment (Health Care), this term only 
#63 MeSH descriptor Guideline Adherence, this term only 












#65 MeSH descriptor Standard of Care, this term only 
#66 MeSH descriptor Reference Standards, this term only 
#67 (best NEXT practice or quality or standard· or benchmark· or adherence or 
requirement·):ti,ab 
#68 (Africa or Asia or Caribbean or "West Indies" or "South America" or "Latin America" or 
"Central America"):ti,ab,kw 
#69 (Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or "Burkina Faso" or "Burkina Fasso" or "Upper Volta" or Burundi or Urundi or 
Cambodia or "Khmer Republic" or Kampuchea or Cameroon or Cameroons or Cameron 
or Camerons or "Cape Verde" or "Central African Republic" or Chad or Chile or China 
or Colombia or Comoros or "Comoro Islands" or Comores or Mayotte or Congo or Zaire 
or "Costa Rica" or "Cote d'Ivoire" or "Ivory Coast" or Croatia or Cuba or Cyprus or 
Czechoslovakia or "Czech Republic" or Slovakia or "Slovak Republic"):ti,ab,kw 
#70 (Djibouti or "French Somaliland" or Dominica or "Dominican Republic" or "East Timor" 
or "East Timur" or "Timor Leste" or Ecuador or Egypt or "United Arab Republic" or "EI 
Salvador" or Eritrea or Estonia or Ethiopia or Fiji or Gabon or "Gabonese Republic" or 
Gambia or Gaza or Georgia or Georgian or Ghana or "Gold Coast" or Greece or Grenada 
or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary 
or India or Maldives or Indonesia or Iran or Iraq or "Isle of Man" or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or "Kyrgyz Republic" or Kirghiz or Kirgizstan or "Lao PDR" or Laos or Latvia 
or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania):ti,ab,kw 
#71 (Macedonia or Madagascar or "Malagasy Republic" or Malaysia or Malaya or Malay or 
Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or "Marshall Islands" or 
Mauritania or Mauritius or "Agalega Islands" or Mexico or Micronesia or "Middle East" 
or Moldova or Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni 
or Mozambique or Myanmar or Myanma or Burma or Namibia or Nepal or "Netherlands 
Antilles" or ''New Caledonia" or Nicaragua or Niger or Nigeria or ''Northern Mariana 
Islands" or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or 
Peru or Philippines or Philipines or Phillipines or Phillippines or Poland or Portugal or 
"Puerto Rico"):ti,ab,kw 
#72 (Romania or Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or "Saint 
Kitts" or "St Kitts" or Nevis or "Saint Lucia" or "St Lucia" or "Saint Vincent" or "St 
Vincent" or Grenadines or Samoa or "Samoan Islands" or "Navigator Island" or 
"Navigator Islands" or "Sao Tome" or "Saudi Arabia" or Senegal or Serbia or 
Montenegro or Seychelles or "Sierra Leone" or Slovenia or "Sri Lanka" or Ceylon or 
"Solomon Islands" or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria 
or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo 
or "Togolese Republic" or Tonga or Trinidad or Tobago or Tunisia or Turkey or 
Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or "Soviet Union" 
or "Union of Soviet Socialist Republics" or Uzbekistan or Uzbek or Vanuatu or "New 
Hebrides" or Venezuela or Vietnam or "VietNam" or "West Bank" or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia):ti,ab,kw 













"middle income" or low* NEXt ihcome or underserved or "under served" or deprived or 
poor*) NEXT (countr* or nation· or population* or world):ti,ab,kw 
#74 (developing or less* NEXT developed or "under developed" or underdeveloped or 
"middle income" or low* NEXT income) NEXT (economy or economies):ti,ab,kw 
#75 low* NEXT (gdp or gnp or "gross domestic" or "gross national"):ti,ab,kw 
#76 (low NEAR/3 middle NEARl3 countr*):ti,ab,kw 
#77 (lmic or lmics or "third world" or "lami country" or "lami countries"):ti,ab,kw 
#78 ("transitional country" or "transitional countries"):ti,ab,kw 
#79 (#2 OR #3 OR #4 OR #5 OR #6) 
#80 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 
OR#18 OR#19 OR #20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR 
#28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 
OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR 
#49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 
OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67) 
#81 (#68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77 OR 
#78) 
#82 (#1 AND #81) 
#83 (#79 AND #80 AND #81) 
#84 (#82 OR #83) 
3. MEDLINE In-Process & Other Non-Indexed Citations and MEDLINE (Ovid) 
# Searches 
1 Public-Private Sector Partnerships! 
2 Private Sector/ 
3 Private Practice/ 
4 Hospitals, Private/ 
5 Privatization! 
6 privat* .ti,ab. 
7 orl2-6 
8 Public Sector/ 
9 Public Policy/ 
10 Health Policy/ 
11 State Medicine/ 
12 State Dentistry/ 
13 Health Care Reform! 
14 Health Planning! 
15 Social Control, Formal! 
16 Law Enforcement! 
17 exp Government! 
18 Government Regulation! 











20 Policy Making! 
21 Jurisprudence/ 
22 Mandatory Reporting! 
23 Politics! 
24 Legislation as Topic/ 
25 Legislation, Hospital! 
26 Legislation, Medical! 
27 Legislation, Nursing! 
28 Legislation, Pharmacy/ 
29 Legislation, Drug! 
30 Legislation, Dental! 
(public· or stewardship· or governance or governing or coordinat· or co ordinat· or 
31 legislat· or regulat· or government· or law or laws or act or acts or policy or policies or 
politics or reform· or control· or supervis* or monitor·).ti,ab. 
32 or/8-31 
33 Physician's Practice Patterns! 
34 Nurse's Practice Patterns! 
35 Dentist's Practice Patterns! 
36 Health Knowledge, Attitudes, Practice/ 
37 Malpractice/ 
38 Professional Impairment! 
39 Physician Impairment! 
40 Medical Errors! 
41 Diagnostic Errors! 
42 Medication Errors! 
43 Professional Competence/ 
44 Clinical Competence/ 
45 (competence or practice pattern· or malpractice or mal practice or error*}.ti,ab. 
46 or/33-45 
47 Education! 
48 Competency-Based Education! 
49 Education, Public Health Professional! 
50 Education, Medical! 
51 Education, Medical, Continuing! 
52 Education, Nursing! 
53 Education, Nursing, Continuing! 
54 Education, Dental! 
55 Education, Dental, Continuing! 
56 Education, Pharmacy/ 
57 Education, Pharmacy, Continuing! 





























lecture? or meeting? or seminar? or support· or symposi· or workshop?).ti,ab. 
or/47-58 
"Delivery of Health Care"/ 
"Quality of Health Care"/ 
Quality Assurance, Health Carel 
Quality Improvement! 
Total Quality Management! 
"Outcome and Process Assessment (health care)"/ 
"Outcome Assessment (health care)"/ 
"Process Assessment (health care)"/ 
Guideline Adherence/ 
Benchmarking! 
"Standard of Care"/ 
Reference Standards! 
(best practice or quality or standard· or benchmark· or adherence or requirement·).ti,ab. 
or/60-72 
Developing Countries.sh,kf. 
(Africa or Asia or Caribbean or West Indies or South America or Latin America or 
Central America).hw,kf,ti,ab,cp. 
(Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or Urundi or 
Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or 
Camerons or Cape Verde or Central African Republic or Chad or Chile or China or 
Colombia or Comoros or Comoro Islands or Comores or Mayotte or Congo or Zaire or 
Costa Rica or Cote d'Ivoire or Ivory Coast or Croatia or Cuba or Cyprus or 
Czechoslovakia or Czech Republic or Slovakia or Slovak Republic or Djibouti or French 
Somaliland or Dominica or Dominican Republic or East Timor or East Timur or Timor 
Leste or Ecuador or Egypt or United Arab Republic or EI Salvador or Eritrea or Estonia 
76 or Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia 
Republic or Georgian Republic or Ghana or Gold Coast or Greece or Grenada or 
Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or 
India or Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or 
Kazakhstan or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or 
Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia or 
Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or 
Madagascar or Malagasy Republic or Malaysia or Malaya or Malay or Sabah or Sarawak 
or Malawi or Nyasaland or Mali or Malta or Marshall Islands or Mauritania or Mauritius 
or Agalega Islands or Mexico or Micronesia or Middle East or Moldova or Moldovia or 
Moldovian or Mongolia or Montenegro or Morocco or Ifui or Mozambique or Myanmar 
or Myanma or Burma or Namibia or Nepal or Netherlands Antilles or New Caledonia or 
Nicaragua or Niger or Nigeria or Northern Mariana Islands or Oman or Muscat or 











or Phillipines or Phillippines or Poland or Portugal or Puerto Rico or Romania or 
Rumania or Roumania or Russia or Russian or Rwanda or Ruanda or Saint Kitts or St 
Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St Vincent or Grenadines or 
Samoa or Samoan Islands or Navigator Island or Navigator Islands or Sao Tome or Saudi 
Arabia or Senegal or Serbia or Montenegro or Seychelles or Sierra Leone or Slovenia or 
Sri Lanka or Ceylon or Solomon Islands or Somalia or Sudan or Suriname or Surinam or 
Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhjk or Tanzania 
or Thailand or Togo or Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or 
Turkey or Turkmenistan or Turkmen or Uganda or Ukraine or Uruguay or USSR or 
Soviet Union or Union of Soviet Socialist Republics or Uzbekistan or Uzbek or Vanuatu 
or New Hebrides or Venezuela or Vietnam or Viet Nam or West Bank or Yemen or 
Yugoslavia or Zambia or Zimbabwe or Rhodesia).hw,kf,ti,ab,cp. 
«developing or less· developed or under developed or underdeveloped or middle income 
77 or low· income or underserved or under served or deprived or poor*) adj (countr· or 
nation? or population? or world».ti,ab. 
78 ( (developing or less* developed or under developed or underdeveloped or middle income 
or low· income) adj (economy or economies».ti,ab. 
79 Qow* adj (gdp or gnp or gross domestic or gross national».ti,ab. 
80 Qow adj3 middle adj3 countr*).ti,ab. 
81 (lmic or lmics or third world or lami countr*).ti,ab. 
82 transitional countr* . ti,ab. 
83 or174-82 
84 randomized controlled trial.pt. 
85 controlled clinical trial.pt. 
86 multicenter study. pt. 
87 (randomis* or randomiz* or randomly or random allocat*).ti,ab. 
88 groups.ab. 
89 (trial or multicenter or multi center or multicentre or multi centre).ti. 
(intervention· or controlled or control group or compare or compared or (before adj5 
90 after) or (pre adj5 post) or pretest or pre test or posttest or post test or quasiexperiment· 





94 92 not (92 and 93) 
95 comment.pt. 
96 editorial.pt. 
97 cochrane database of systematic reviews.jn. 















10291 not 101 
103 1 and 83 and 102 
104 7 and 32 and 83 and 102 
1057 and 46 and 83 and 102 
1067 and 59 and 83 and 102 
1077 and 73 and 83 and 102 
108 or/l 03-1 07 
4. EMBASE (Ovid) 
## Searches 
1 "organization and management"/ 
2 government regulation! 
3 social controV 
4 professional competence/ 
5 clinical competence/ 
6 quality controV 
7 health care quality/ 
8 total quality management! 
9 or/2-8 
101 and 9 
(privat* adj6 (public* or stewardship* or governance or governing or coordinat* or co 
11 ordinat* or legislat* or regulat* or government* or law or laws or act or acts or policy or 
policies or politics or reform* or control* or supervis* or monitor*)).ti,ab. 
12 (privat* adj6 (competence or practice pattern* or malpractice or mal practice or 
error*)).ti,ab. 
13 (privat* adj6 (educat* or train or training or trained or colloquium? or conference? or 
course? or lecture? or meeting? or seminar? or support* or symposi* or workshop?)).ti,ab. 
14 (privat* adj6 (best practice or quality or standard* or benchmark* or adherence or 
requirement*)).ti,ab. 
150r/1l-14 
1610 or 15 
17 Developing Country.sh. 
18 (Africa or Asia or Caribbean or West Indies or South America or Latin America or Central 
America).hw,ti,ab,cp. 
(Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda or Argentina or 
Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or 
Benin or Byelarus or Byelorussian or Belarus or Belorussian or Belorussia or Belize or 
Bhutan or Bolivia or Bosnia or Herzegovina or Hercegovina or Botswana or Brazil or 
19 Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or Urundi or 
Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or 
Camerons or Cape Verde or Central African Republic or Chad or Chile or China or 
Colombia or Comoros or Comoro Islands or Comores or Mayotte or Congo or Zaire or 











Czechoslovakia or Czech Republic or Slovakia or Slovak Republic or Djibouti or French 
Somaliland or Dominica or Dominican Republic or East Timor or East Timur or Timor 
Leste or Ecuador or Egypt or United Arab Republic or EI Salvador or Eritrea or Estonia or 
Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia Republic 
or Georgian Republic or Ghana or Gold Coast or Greece or Grenada or Guatemala or 
Guinea or Guam or Guiana or Guyana or Haiti or Honduras or Hungary or India or 
Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan 
or Kazakh or Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz 
Republic or Kirghiz or Kirgizstan or Lao PDR or Laos or Latvia or Lebanon or Lesotho or 
Basutoland or Liberia or Libya or Lithuania or Macedonia or Madagascar or Malagasy 
Republic or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland 
or Mali or Malta or Marshall Islands or Mauritania or Mauritius or Agalega Islands or 
Mexico or Micronesia or Middle East or Moldova or Moldovia or Moldovian or Mongolia 
or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or 
Namibia or Nepal or Netherlands Antilles or New Caledonia or Nicaragua or Niger or 
Nigeria or Northern Mariana Islands or Oman or Muscat or Pakistan or Palau or Palestine 
or Panama or Paraguay or Peru or Philippines or Philipines or Phillipines or Phillippines 
or Poland or Portugal or Puerto Rico or Romania or Rumania or Roumania or Russia or 
Russian or Rwanda or Ruanda or Saint Kitts or St Kitts or Nevis or Saint Lucia or St 
Lucia or Saint Vincent or St Vincent or Grenadines or Samoa or Samoan Islands or 
Navigator Island or Navigator Islands or Sao Tome or Saudi Arabia or Senegal or Serbia 
or Montenegro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or Ceylon or 
Solomon Islands or Somalia or Sudan or Suriname or Surinam or Swaziland or Syria or 
Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or Tanzania or Thailand or Togo or 
Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan 
or Turkmen or Uganda or Ukraine or Uruguay or USSR or Soviet Union or Union of 
Soviet Socialist Republics or Uzbekistan or Uzbek or Vanuatu or New Hebrides or 
Venezuela or Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia or Zambia or 
Zimbabwe or Rhodesia).hw,ti,ab,cp. 
«developing or less· developed or under developed or underdeveloped or middle income 
20 or low· income or underserved or under served or deprived or poor·) adj (countr· or 
nation? or population? or world».ti,ab. 
21 «developing or less· developed or under developed or underdeveloped or middle income 
or low· income) adj (economy or economies».ti,ab. 
22 (low· adj (gdp or gnp or gross domestic or gross national».ti,ab. 
23 (low adj3 middle adj3 countr·).ti,ab. 
24 (lmic or lmics or third world or lami countr·).ti,ab. 
25 transitional countr· .ti,ab. 
26or117-25 
27 Randomized Controlled TriaV 
28 Controlled Clinical TriaV 
29 Quasi Experimental Study/ 
30 Pretest Posttest Control Group Design! 
31 Time Series Analysis! 
32 Experimental Design! 










34 (randomis* or randomiz* or randomly or random allocat*).ti,ab. 
35 groups.ab. 
36 (trial or multicentre or multicenter or multi centre or multi center).ti. 
(intervention* or controlled or control group or compare or compared or (before adj5 
37 after) or (pre adj5 post) or pretest or pre test or posttest or post test or quasiexperiment* or 




40 "cochrane database of systematic reviews" .jn. 
41 Nonhuman! 
42or/39-41 
4338 not 42 
44 16 and 26 and 43 
45 15 and 26 and 43 
46 limit 45 to embase 




TS=(stewardship* or governance or governing or policy or policies or politics or coordinat* 
or legislat* or regulat* or supervis* or monitor*) 
AND 
TS=(health* or medical* or pharmac* or drug or drugs or doctor* or physiscan* or nurse or 
nurses or hospital*) 
AND 
TS=( developing or less developed or lesser developed or underdeveloped or under developed 
or middle income or low income or lower income or transitional) AND TS=( countr* or 
nationS or populationS or world) OR TS=(lmic or lmics) 
AND 
TS=(randomis* or randomiz* or impact or effect or evaluat* or control* or intervention* or 
"time series" or "time point" or "time points" or "repeated measure" or "repeated measures" 


















TS=(partnership$ or engagementS or collaborat*) 
AND 
TS=(health* or medical* or pharmac* or drug or drugs or doctor* or physiscan* or nurse or 
nurses or hospital*) 
AND 
TS=( developing or less developed or lesser developed or underdeveloped or under developed 
or middle income or low income or lower income or transitional) AND TS=(countr* or 
nationS or populationS or world) OR TS=(lmic or lmics) 
AND 
TS=(randomis* or randomiz* or impact or effect or evaluat* or control* or intervention* or 
"time series" or "time point" or "time points" or "repeated measure" or "repeated measures" 
or quasiexperiment* or "quasi experiment") 
6. WBOLIS (WHO) 
Searched in field: Words or phrase 
privatS AND public AND stewardshipS or governS or policy or policies or politics or 
coordinatS or co ordinatS or legislatS or regulatS or supervis$ or monitorS or partnerS or 
engagementS or collaborat$ AND random$ or impactS or effectS or evaluatS or controlS or 
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